{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":87,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":87,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"6cd95c356a07","filters":{"venue":"Seminars in Oncology"}},"results":[{"id":"W1975826537","doi":"10.1053/j.seminoncol.2004.03.042","title":"The role of COX-2 inhibition in breast cancer treatment and prevention","year":2004,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Celecoxib; Aromatase; Breast cancer; Exemestane; Internal medicine; Oncology; Cancer; Angiogenesis; Cancer research","authors":[{"name":"Banu Arun","is_ca":false},{"name":"Paul E. Goss","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0147704007122809,"gpt":0.3580283085129214,"spread":0.3432579078006405,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006262837,0.0006667713,0.001633122,0.001296433,0.000212692,0.0007442406,0.0006980394,0.0008918441,0.0034432],"category_scores_gemma":[0.000631306,0.0002513936,0.0004850358,0.001678875,0.0004083231,0.0009043244,0.0003874135,0.001634823,0.001604952],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004601315,"about_ca_system_score_gemma":0.0008882123,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001314472,"about_ca_topic_score_gemma":0.004027768,"domain_scores_codex":[0.999878,0.00002432423,0.00001782625,0.00001815347,0.0000466388,0.00001491635],"domain_scores_gemma":[0.9996769,0.0001682906,0.00005356281,0.000009657073,0.00006739682,0.00002421686],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000334281,0.0001192004,0.0002242592,0.01067145,0.0001726756,0.000249895,0.00003451158,0.00037176,0.002093883,0.00146088,0.01911273,0.9651545],"study_design_scores_gemma":[0.0001848444,0.0004448295,0.002616431,0.003838968,0.0004451788,0.001675174,0.00008786521,0.0001831464,0.001214789,0.001963489,0.987317,0.00002816806],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001321918,0.9990541,0.00006151971,0.0001863645,0.0001418246,0.000002245033,0.00001123732,0.000003322246,0.0004070818],"genre_scores_gemma":[0.0009861726,0.9981143,0.0001512739,0.0001699254,0.0001544247,0.000004184705,0.00001760196,7.935432e-7,0.0004013107],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0034432,"threshold_uncertainty_score":0.01151872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2070471476","doi":"10.1053/j.seminoncol.2005.07.008","title":"Epigenetic Therapy of Cancer With 5-Aza-2′-Deoxycytidine (decitabine)","year":2005,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":197,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Decitabine; Azacitidine; Cancer research; DNA methylation; Medicine; Leukemia; Cancer; Epigenetics; Epigenetic therapy; Pharmacology; Biology; Immunology; Internal medicine; Genetics; Gene; Gene expression","authors":[{"name":"Richard L. Momparler","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04006985032835864,"gpt":0.3993805884429653,"spread":0.3593107381146066,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003209699,0.0006733802,0.001196805,0.000845127,0.000215005,0.0004228746,0.000913949,0.0007478003,0.002276877],"category_scores_gemma":[0.0002058723,0.0001818533,0.0002821772,0.0008578741,0.0003230427,0.0003858811,0.0003544671,0.001151348,0.00159046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006778348,"about_ca_system_score_gemma":0.0003755836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001160423,"about_ca_topic_score_gemma":0.003184658,"domain_scores_codex":[0.9999297,0.00001066646,0.00000699772,0.00001659434,0.00002425795,0.00001169558],"domain_scores_gemma":[0.999943,0.00002487133,0.000009413219,0.000003328178,0.00001238139,0.000006918495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001583543,0.00008388681,0.0001201161,0.003344172,0.00007347764,0.0003211723,0.00003594721,0.0004006486,0.01289985,0.002656128,0.01742047,0.9624857],"study_design_scores_gemma":[0.00009131373,0.0002165889,0.001267001,0.0005868798,0.0001296592,0.002393208,0.00003219856,0.0001847359,0.01425283,0.001085406,0.9797413,0.00001883909],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007959529,0.995423,0.0007884771,0.0003122659,0.0004630828,0.00001061104,0.00002309553,0.00002311287,0.002160464],"genre_scores_gemma":[0.005370762,0.9894553,0.000810521,0.0003292272,0.0002184359,0.00001810234,0.00006384991,0.000004204403,0.0037296],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002276877,"threshold_uncertainty_score":0.007616878,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026309863","doi":"10.1053/j.seminoncol.2013.09.004","title":"Risk-Based Health Care, the Cancer Survivor, the Oncologist, and the Primary Care Physician","year":2013,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Centers for Disease Control and Prevention","keywords":"Survivorship curve; Medicine; Psychological intervention; Health care; Family medicine; Cancer survivorship; Quality of life (healthcare); Cancer survivor; Population; Cancer; MEDLINE; Intervention (counseling); Nursing; Environmental health; Internal medicine","authors":[{"name":"Mary S. McCabe","is_ca":false},{"name":"Ann H. Partridge","is_ca":false},{"name":"Eva Grunfeld","is_ca":true},{"name":"Melissa M. Hudson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03204789974542294,"gpt":0.3751807080466998,"spread":0.3431328083012768,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001049275,0.0007864892,0.001664257,0.002078751,0.0004514767,0.001237691,0.0010779,0.001973832,0.005928433],"category_scores_gemma":[0.002918418,0.0003167629,0.0007490909,0.002662852,0.0005587573,0.001452149,0.0009384956,0.002078224,0.0009553727],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00174485,"about_ca_system_score_gemma":0.003134427,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005458664,"about_ca_topic_score_gemma":0.02238913,"domain_scores_codex":[0.9994061,0.0001724093,0.0000790072,0.0000632385,0.0002336608,0.00004563899],"domain_scores_gemma":[0.9986519,0.0008605029,0.0001856919,0.00001502848,0.0001984443,0.0000884091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006078759,0.00006799187,0.000485304,0.05128011,0.0003086142,0.0001358842,0.0000925335,0.0001353771,0.0001582788,0.003820751,0.08906333,0.854391],"study_design_scores_gemma":[0.00009353553,0.00006122813,0.003025217,0.07724417,0.0005750652,0.001116703,0.0003089031,0.00007254916,0.00007883726,0.002309334,0.9150868,0.00002761738],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003147957,0.9986346,0.00001842162,0.0005976839,0.0001730537,0.000003009621,0.000005779777,0.000001410336,0.0005346417],"genre_scores_gemma":[0.000482969,0.9985678,0.00005106078,0.0004973529,0.0001876318,0.000004397487,0.000009994722,3.416123e-7,0.000198403],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005928433,"threshold_uncertainty_score":0.01983255,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2119780823","doi":"10.1053/j.seminoncol.2009.03.003","title":"Cancer in Young Adults 20 to 39 Years of Age: Overview","year":2009,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"","keywords":"Medicine; Psychosocial; Young adult; Cancer; Epidemiology; Disease; Etiology; Ethnic group; Gerontology; Depression (economics); Pediatrics; Psychiatry; Internal medicine","authors":[{"name":"Archie Bleyer","is_ca":false},{"name":"Ronald D. Barr","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05565798392498606,"gpt":0.4336531959786632,"spread":0.3779952120536771,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004371556,0.0006746138,0.001713606,0.002748387,0.0002152154,0.0005869807,0.0004190774,0.0006284926,0.002084982],"category_scores_gemma":[0.0009486169,0.0002742789,0.0008436397,0.003097739,0.0001942746,0.0007593753,0.0004594552,0.0006311592,0.000282323],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008240419,"about_ca_system_score_gemma":0.001908312,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005131774,"about_ca_topic_score_gemma":0.01689813,"domain_scores_codex":[0.9998318,0.00003131296,0.00004430637,0.00002706163,0.00004675215,0.00001870358],"domain_scores_gemma":[0.9995244,0.0002395263,0.0001411542,0.000004469447,0.00006135368,0.00002913151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001213388,0.00007548601,0.002295608,0.1033836,0.0005484876,0.0002659293,0.0001504362,0.0002108398,0.000386982,0.0007137789,0.02424406,0.8676035],"study_design_scores_gemma":[0.0001486001,0.0006814282,0.04040666,0.1549962,0.005369441,0.00563377,0.0009148362,0.0002150982,0.0005033179,0.001002221,0.7900573,0.00007120195],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001749046,0.9994167,0.00001567299,0.0001146699,0.00004856625,0.000004326739,0.00002559098,0.000001410932,0.0001982262],"genre_scores_gemma":[0.001013643,0.998693,0.00004705144,0.00009168962,0.00003930365,0.000006106176,0.00001897105,2.39421e-7,0.0000899697],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005131774,"threshold_uncertainty_score":0.01020384,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130773839","doi":"10.1016/s0093-7754(01)90290-8","title":"The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"National Cancer Institute","keywords":"PTEN; Cancer research; Medicine; Ovarian cancer; Breast cancer; Carcinogenesis; Cowden syndrome; Tumor suppressor gene; Oncology; PI3K/AKT/mTOR pathway; Cancer; Internal medicine; Signal transduction; Biology; Genetics","authors":[{"name":"Gordon B. Mills","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01068779914321886,"gpt":0.2841705723610131,"spread":0.2734827732177942,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001041173,0.0008204303,0.001611962,0.001601411,0.0002574177,0.0009250697,0.001225143,0.001432206,0.001865976],"category_scores_gemma":[0.001126929,0.0002376323,0.0003361563,0.002121432,0.0006238383,0.0009920218,0.0004508716,0.001648555,0.001502959],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008279079,"about_ca_system_score_gemma":0.0009652081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001596575,"about_ca_topic_score_gemma":0.003347493,"domain_scores_codex":[0.99978,0.00004452751,0.00002776008,0.00003412266,0.00009104592,0.00002253317],"domain_scores_gemma":[0.9994808,0.0003003074,0.00004746131,0.00001509874,0.0001080311,0.00004839902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002135537,0.00008859455,0.0007106017,0.003054268,0.00008960169,0.0006098272,0.00003422422,0.0006244129,0.001689487,0.002712518,0.03375521,0.9564176],"study_design_scores_gemma":[0.0000943589,0.0002172757,0.004342352,0.001701894,0.0002533128,0.00566148,0.00009432759,0.000326686,0.0009820957,0.004386227,0.981902,0.00003790702],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002014639,0.9980008,0.0002046509,0.00051826,0.0002047958,0.000002766466,0.00001302089,0.000007971334,0.0008462917],"genre_scores_gemma":[0.001264682,0.9973989,0.0002596566,0.0002260655,0.0002666498,0.000004891776,0.00002025106,0.000001074783,0.0005579362],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001865976,"threshold_uncertainty_score":0.006242335,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089410776","doi":"10.1016/s0093-7754(01)90035-1","title":"Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Québec Metro High Tech Park (Canada)","funders":"","keywords":"Medicine; Angiogenesis; Vascular endothelial growth factor; In vivo; Lewis lung carcinoma; Pharmacology; Matrigel; Neovascularization; Blood vessel; Thalidomide; Basic fibroblast growth factor; Cancer research; Bone marrow; Matrix metalloproteinase inhibitor; Matrix metalloproteinase; Cancer; Immunology; Internal medicine; Growth factor; Multiple myeloma; Receptor; Biology; VEGF receptors; Metastasis","authors":[{"name":"Pierre Falardeau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2441527530475329,"gpt":0.5670275841619712,"spread":0.3228748311144383,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001619886,0.0008809957,0.002626662,0.001061696,0.0002660849,0.0009747852,0.0009734715,0.001048829,0.003446907],"category_scores_gemma":[0.0009035798,0.0002210024,0.0006182141,0.001868268,0.0003470021,0.0008454609,0.0003500351,0.001526564,0.001453443],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005117079,"about_ca_system_score_gemma":0.001238558,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007907602,"about_ca_topic_score_gemma":0.002371581,"domain_scores_codex":[0.9998266,0.0000397457,0.00002190971,0.0000278905,0.00006100245,0.00002278276],"domain_scores_gemma":[0.9995936,0.0002111873,0.00006751168,0.0000122064,0.00005927197,0.0000563088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001001442,0.0002739122,0.0002813944,0.009216054,0.0001640184,0.0002589411,0.00004064943,0.0004295473,0.003505283,0.0009654643,0.01603637,0.9678268],"study_design_scores_gemma":[0.003181553,0.005529213,0.004013382,0.006088535,0.001569279,0.003911757,0.0001402722,0.0005639173,0.006724888,0.001956099,0.9662572,0.00006391882],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001577138,0.9953382,0.0004461708,0.0004219614,0.0002153624,0.00005516156,0.0000775735,0.00002762915,0.001840753],"genre_scores_gemma":[0.005685453,0.9908419,0.0009958022,0.000677027,0.0001245714,0.00007164793,0.0002013976,0.000005063821,0.001397089],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003446907,"threshold_uncertainty_score":0.01153105,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2072648699","doi":"10.1053/j.seminoncol.2014.04.006","title":"Platelets Effects on Tumor Growth","year":2014,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Intravasation; Platelet; Extravasation; Medicine; Metastasis; Cancer research; Cancer; Cancer cell; Primary tumor; Tumor microenvironment; Tumor cells; Cell biology; Immunology; Pathology; Biology; Internal medicine","authors":[{"name":"Hadi Goubran","is_ca":false},{"name":"Julie Stakiw","is_ca":true},{"name":"Mirjana Radosevic","is_ca":false},{"name":"Thierry Burnouf","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0204864022016315,"gpt":0.3599807626362805,"spread":0.339494360434649,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004282738,0.001010269,0.001671484,0.001812242,0.0001986737,0.001064306,0.0005321603,0.001006301,0.003744778],"category_scores_gemma":[0.0008042633,0.0003780862,0.000539293,0.001810579,0.0003637868,0.0008179714,0.0007826411,0.001574467,0.00131604],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003872799,"about_ca_system_score_gemma":0.0009440351,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008115821,"about_ca_topic_score_gemma":0.001852969,"domain_scores_codex":[0.9998417,0.00002798337,0.00003487732,0.00002464559,0.00005407487,0.00001659883],"domain_scores_gemma":[0.9997721,0.0001045887,0.00005318085,0.000007080778,0.00004435814,0.00001875687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002804857,0.00009203699,0.0003064423,0.02992095,0.000320033,0.0002528601,0.00004572781,0.0003275866,0.001580911,0.001266977,0.02867137,0.9369345],"study_design_scores_gemma":[0.0002595049,0.0004058826,0.003078328,0.01236511,0.001673616,0.00196376,0.0001119382,0.0002560016,0.001882885,0.002007775,0.9759383,0.00005692357],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001022268,0.999218,0.0000414149,0.0001418893,0.0001347672,0.000003813921,0.00001593629,0.000003192911,0.000338792],"genre_scores_gemma":[0.00100949,0.9981672,0.00008169722,0.0001647621,0.0001684437,0.000006864649,0.00002545778,7.338155e-7,0.0003752857],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003744778,"threshold_uncertainty_score":0.01252753,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2755955412","doi":"10.1053/j.seminoncol.2017.08.004","title":"Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients","year":2017,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Ovarian cancer; Olaparib; Medicine; Germline; Genetic testing; Germline mutation; PARP inhibitor; Oncology; Cancer; Somatic cell; Breast cancer; Internal medicine; BRCA mutation; Mutation; Cancer research; Gynecology; Polymerase; Poly ADP ribose polymerase; Genetics; DNA; Biology; Gene","authors":[{"name":"Ettore Capoluongo","is_ca":false},{"name":"Gillian Ellison","is_ca":false},{"name":"José Antonio López‐Guerrero","is_ca":false},{"name":"Frédérique Penault‐Llorca","is_ca":false},{"name":"Marjolijn J. L. Ligtenberg","is_ca":false},{"name":"Susana Banerjee","is_ca":false},{"name":"Christian F. Singer","is_ca":false},{"name":"Eitan Friedman","is_ca":false},{"name":"Birgid Markiefka","is_ca":false},{"name":"Peter Schirmacher","is_ca":false},{"name":"Reinhard Büttner","is_ca":false},{"name":"Christi J. van Asperen","is_ca":false},{"name":"Isabelle Ray‐Coquard","is_ca":false},{"name":"Volker Endris","is_ca":false},{"name":"Suzanne Kamel‐Reid","is_ca":true},{"name":"Natalie Percival","is_ca":false},{"name":"Jane Bryce","is_ca":false},{"name":"Benno Röthlisberger","is_ca":false},{"name":"Richie Soong","is_ca":false},{"name":"David González de Castro","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07812918806627712,"gpt":0.4238238305409072,"spread":0.3456946424746301,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002659885,0.0007200691,0.001006158,0.001598131,0.000431269,0.0009486182,0.002076649,0.005414822,0.004984064],"category_scores_gemma":[0.005125008,0.0003966103,0.001028002,0.001313168,0.0008406482,0.001250081,0.001039101,0.004942477,0.004608384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001528767,"about_ca_system_score_gemma":0.004594688,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004834209,"about_ca_topic_score_gemma":0.007365453,"domain_scores_codex":[0.9988008,0.0003224881,0.0001976479,0.00009708814,0.0004995191,0.00008253542],"domain_scores_gemma":[0.9973791,0.001057772,0.0003155271,0.00005853075,0.0009923228,0.0001968295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003994931,0.00004867856,0.0001628292,0.004263081,0.00002750126,0.000334879,0.00007096027,0.0002490488,0.0005068471,0.006579933,0.5946088,0.3931074],"study_design_scores_gemma":[0.00001548601,0.00002119945,0.0002604603,0.002973938,0.00001786562,0.0006140703,0.00001891494,0.00003000384,0.0001099846,0.001260219,0.9946694,0.000008346502],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004730347,0.8726984,0.002606068,0.0749254,0.01144149,0.0002263939,0.001201564,0.0002205383,0.03620709],"genre_scores_gemma":[0.002878224,0.9232842,0.005904105,0.04489072,0.002869325,0.0003670342,0.001927425,0.00004944505,0.01782957],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005414822,"threshold_uncertainty_score":0.01667333,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1994549184","doi":"10.1053/j.seminoncol.2010.05.008","title":"The Role of Physical Activity in Breast Cancer Etiology","year":2010,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Physical Activity and Health","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Breast cancer; Observational study; Population; Cancer; Randomized controlled trial; Epidemiology; Cancer prevention; Incidence (geometry); Gerontology; Internal medicine; Demography; Physical therapy; Environmental health","authors":[{"name":"Christine M. Friedenreich","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03902035306381191,"gpt":0.4383813560156303,"spread":0.3993610029518184,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008060037,0.001045483,0.002203272,0.002458313,0.0002426195,0.001130681,0.000985998,0.001228257,0.003059295],"category_scores_gemma":[0.001246858,0.0004195039,0.0008790838,0.00345774,0.0006664158,0.001258987,0.0008879199,0.001610339,0.001262158],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006225125,"about_ca_system_score_gemma":0.00150464,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0033779,"about_ca_topic_score_gemma":0.005586694,"domain_scores_codex":[0.9997385,0.00005386224,0.0000472969,0.00005622938,0.00008286889,0.00002121954],"domain_scores_gemma":[0.9993643,0.0004044656,0.00009764922,0.00001193249,0.00009428731,0.00002732922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001098789,0.00007208814,0.001030887,0.02902707,0.0004228354,0.0002028792,0.00005066856,0.0003114414,0.000493277,0.001389311,0.01358008,0.9533094],"study_design_scores_gemma":[0.0001021014,0.0002136863,0.01300778,0.02689598,0.001591154,0.00231871,0.0002942886,0.0002974749,0.0004234536,0.003821603,0.9509667,0.00006715753],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005436453,0.9994928,0.00002798591,0.0001172278,0.00007801439,0.000001351418,0.000007805313,0.000001329679,0.0002191892],"genre_scores_gemma":[0.0004455469,0.999212,0.00005244068,0.00007916161,0.00009462973,0.000001802857,0.00001288969,3.928603e-7,0.0001010753],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0033779,"threshold_uncertainty_score":0.01023436,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111959414","doi":"10.1016/s0093-7754(01)90215-5","title":"The effect of hemoglobin level on radiotherapy outcomes: The Canadian experience","year":2001,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Blood transfusion and management","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Univariate analysis; Anemia; Multivariate analysis; Internal medicine; Retrospective cohort study; Blood transfusion; Hemoglobin; Carcinoma; Stage (stratigraphy); Regimen; Surgery; Gastroenterology","authors":[{"name":"Grégoire Thomas","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02303835331426013,"gpt":0.3452024190128664,"spread":0.3221640656986063,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001944112,0.0003731359,0.0005155646,0.0009084598,0.003548454,0.001445215,0.001268871,0.000824122,0.00334179],"category_scores_gemma":[0.007529643,0.0002631796,0.0005556025,0.004375404,0.001403863,0.0004785898,0.0007470723,0.001266333,0.0002580805],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05704181,"about_ca_system_score_gemma":0.05826882,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9852071,"about_ca_topic_score_gemma":0.9937936,"domain_scores_codex":[0.9979994,0.0002354739,0.00007809381,0.0001411625,0.0009480255,0.0005978452],"domain_scores_gemma":[0.994306,0.0008173253,0.0006565411,0.0001352423,0.002090147,0.001994722],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00114048,0.0005320216,0.8967906,0.0001403981,0.0001732325,0.001019262,0.005118022,0.0006845011,0.0003528619,0.001190083,0.01655647,0.07630203],"study_design_scores_gemma":[0.00008259126,0.0003041681,0.9821267,0.0001303719,0.0001248913,0.0007088463,0.003916461,0.0002437776,0.000170899,0.0001725124,0.01194442,0.00007438358],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9667929,0.00468464,0.0001631193,0.007083532,0.0001187052,0.00005575733,0.001568484,0.00001489201,0.01951792],"genre_scores_gemma":[0.9908293,0.005050482,0.0003032648,0.0007333122,0.00006594745,0.00001927388,0.0005889279,0.00002559999,0.002383793],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05704181,"threshold_uncertainty_score":0.4138692,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107019084","doi":"10.1053/j.seminoncol.2011.05.009","title":"Treatment of Metastatic Colorectal Cancer","year":2011,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Alberta Heritage Foundation for Medical Research","keywords":"Medicine; Colorectal cancer; Oncology; Chemotherapy; Internal medicine; Fluorouracil; Bevacizumab; Monoclonal antibody; Cancer; Antibody; Immunology","authors":[{"name":"Janine M. Davies","is_ca":false},{"name":"Richard M. Goldberg","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0568908873638325,"gpt":0.3674241264027722,"spread":0.3105332390389396,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001866015,0.0001459854,0.0002340256,0.0003744838,0.0002473368,0.0002564586,0.0001675474,0.0002268726,0.00669842],"category_scores_gemma":[0.0004487874,0.00004473991,0.0003812763,0.0004322328,0.0001385897,0.0001824078,0.0002213155,0.000416504,0.000989099],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003564583,"about_ca_system_score_gemma":0.0002965502,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007038141,"about_ca_topic_score_gemma":0.00210948,"domain_scores_codex":[0.9999137,0.00003296207,0.000004596869,0.000009428251,0.00002130986,0.00001795526],"domain_scores_gemma":[0.9999154,0.0000193598,0.00001871389,0.00000712112,0.00001067873,0.00002875485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002674147,0.0005091956,0.007281503,0.002025048,0.0001688125,0.001389341,0.0001076739,0.0004219889,0.01002901,0.002577643,0.0290774,0.9437382],"study_design_scores_gemma":[0.00207699,0.01403188,0.1300236,0.001557271,0.0005787325,0.01552044,0.0002583896,0.0005618079,0.0119806,0.003328708,0.820049,0.0000325544],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2901936,0.4891772,0.002523889,0.01961221,0.003174172,0.000308445,0.001035382,0.0001529691,0.1938222],"genre_scores_gemma":[0.8207711,0.1331808,0.001642636,0.005170262,0.002430933,0.0001796739,0.001032663,0.00002698646,0.03556492],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.00669842,"threshold_uncertainty_score":0.02240849,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034666734","doi":"10.1016/s0093-7754(01)90261-1","title":"Zoledronic acid in the treatment of hypercalcemia of malignancy: Results of the international clinical development program","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Zoledronic acid; Medicine; Bisphosphonate; Internal medicine; Clinical trial; Urology; Refractory (planetary science); Randomized controlled trial; Malignancy; Gastroenterology; Surgery; Osteoporosis","authors":[{"name":"Pierre Major","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.128744099947459,"gpt":0.4871120132950055,"spread":0.3583679133475465,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001628974,0.0006852036,0.001602678,0.001868379,0.0001360984,0.0007977092,0.0009084283,0.0008961704,0.001640056],"category_scores_gemma":[0.001199288,0.000224711,0.0007530729,0.003196458,0.0003417505,0.0006878643,0.0003451313,0.0008989263,0.0006482166],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008794009,"about_ca_system_score_gemma":0.00202067,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003532533,"about_ca_topic_score_gemma":0.008630145,"domain_scores_codex":[0.9997221,0.00004687631,0.00005921371,0.00003413487,0.0001113703,0.00002621005],"domain_scores_gemma":[0.9991566,0.0004268347,0.0001236146,0.00001758742,0.0002106982,0.00006469096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007753184,0.000196959,0.0004240141,0.01603368,0.0002342343,0.0002171567,0.00004451971,0.0005107051,0.001493693,0.001117448,0.01676581,0.9621865],"study_design_scores_gemma":[0.001511581,0.0021048,0.01297383,0.00929838,0.002407019,0.003523494,0.0001549992,0.0004512064,0.002779524,0.001169398,0.9635667,0.00005929661],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004729695,0.9987184,0.00006252245,0.0001843239,0.00007135618,0.000009093775,0.00002663603,0.000004761996,0.0004500082],"genre_scores_gemma":[0.001844768,0.9973155,0.0002344703,0.0002232693,0.00005865934,0.000007847036,0.00005786447,9.33273e-7,0.0002567362],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003532533,"threshold_uncertainty_score":0.008614957,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2000894976","doi":"10.1053/j.seminoncol.2005.07.017","title":"Brief Communication: A New Combination in the Treatment of Advanced Pancreatic Cancer","year":2005,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Gemcitabine; Medicine; Pancreatic cancer; Erlotinib; Oncology; Internal medicine; Chemotherapy; Cancer; Antimetabolite; Epidermal growth factor receptor","authors":[{"name":"Malcolm J. Moore","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03840506350717299,"gpt":0.4089849440371781,"spread":0.3705798805300051,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001049874,0.0007602246,0.001410789,0.001023521,0.0007941123,0.0009693007,0.0006819402,0.004396634,0.0126498],"category_scores_gemma":[0.001316051,0.0002150882,0.001001402,0.0007390037,0.0006413608,0.001083684,0.000416879,0.003665488,0.002934952],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000451416,"about_ca_system_score_gemma":0.0004630783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003097594,"about_ca_topic_score_gemma":0.001181797,"domain_scores_codex":[0.999443,0.0002360546,0.00005820504,0.00005882356,0.0001273277,0.00007653017],"domain_scores_gemma":[0.9992363,0.0004585055,0.00005888071,0.00003374779,0.0000712515,0.0001412913],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"case_report","study_design_scores_codex":[0.007031128,0.0005943737,0.001698056,0.00181433,0.000256455,0.01197517,0.00008233303,0.0006068521,0.0072375,0.002678314,0.5499511,0.4160743],"study_design_scores_gemma":[0.002379876,0.007765286,0.006747173,0.0003490828,0.0004615451,0.01694818,0.0001106321,0.0007424176,0.006448121,0.002533614,0.9554058,0.0001083496],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.05234019,0.3113463,0.007162548,0.2500173,0.2829895,0.0006489939,0.001443608,0.0006793215,0.0933722],"genre_scores_gemma":[0.1722551,0.1553492,0.008091598,0.1587405,0.3789911,0.0003983575,0.001230157,0.0001760393,0.1247681],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0126498,"threshold_uncertainty_score":0.04231781,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130986264","doi":"10.1016/s0093-7754(01)90297-0","title":"Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Docetaxel; Medicine; Vinorelbine; Ifosfamide; Lung cancer; Chemotherapy; Internal medicine; Oncology; Phases of clinical research; Cancer; Surgery; Cisplatin","authors":[{"name":"F SHEPHERD","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1612092728561817,"gpt":0.5138659854352491,"spread":0.3526567125790674,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001315321,0.0006984749,0.003357925,0.0009681585,0.0001717549,0.0006740183,0.0007553059,0.0006811782,0.00219715],"category_scores_gemma":[0.001579363,0.0002562198,0.001539211,0.001634428,0.0002549853,0.0005255483,0.0002128234,0.0008190763,0.0003156673],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005881371,"about_ca_system_score_gemma":0.0009895132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001397612,"about_ca_topic_score_gemma":0.006327126,"domain_scores_codex":[0.9997804,0.00007000896,0.00004586197,0.0000375319,0.00005314514,0.00001310652],"domain_scores_gemma":[0.9990514,0.000701303,0.000138644,0.00001537534,0.00006336272,0.00002990869],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.002512303,0.000119962,0.0006518408,0.09037754,0.00255554,0.0002354753,0.00007863874,0.0005119068,0.001627413,0.0004005012,0.01178059,0.8891482],"study_design_scores_gemma":[0.01117861,0.01044478,0.02801034,0.08022431,0.05029492,0.007610886,0.0004317053,0.0007899757,0.005245638,0.001983239,0.8036032,0.0001824991],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001378702,0.9978073,0.00007434814,0.0001995067,0.0000514201,0.00002690858,0.00007974733,0.000005231676,0.0003768757],"genre_scores_gemma":[0.007076678,0.991964,0.0002306235,0.000347988,0.00004084537,0.00002277432,0.000083161,0.000002023023,0.0002318693],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003357925,"threshold_uncertainty_score":0.007350206,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089735828","doi":"10.1053/j.seminoncol.2011.01.018","title":"Differential Properties of Current Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors","year":2011,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Novartis Pharmaceuticals Canada","keywords":"Sunitinib; Medicine; Regorafenib; Dasatinib; GiST; Imatinib; Nilotinib; Tyrosine kinase; Sorafenib; Tyrosine-kinase inhibitor; Imatinib mesylate; Pazopanib; Oncology; Internal medicine; Cancer research; Pharmacology; Cancer; Stromal cell; Colorectal cancer; Hepatocellular carcinoma; Receptor","authors":[{"name":"George D. Demetri","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.105111664891162,"gpt":0.3827375051002066,"spread":0.2776258402090446,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000758455,0.0008577846,0.001820407,0.001773567,0.0001688785,0.001077282,0.000800685,0.0007577969,0.001941065],"category_scores_gemma":[0.0008565363,0.0002951476,0.0007125041,0.002013607,0.0003996203,0.001245816,0.0004745221,0.001606956,0.0009526432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005739015,"about_ca_system_score_gemma":0.0005232258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00063366,"about_ca_topic_score_gemma":0.001861979,"domain_scores_codex":[0.9997969,0.00002785071,0.000038737,0.00004031058,0.00007389833,0.00002226109],"domain_scores_gemma":[0.9995723,0.0002414902,0.00007841871,0.00001009908,0.00007474257,0.00002300079],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002024157,0.00007131261,0.0003516848,0.01001398,0.0001510346,0.000306826,0.00004643318,0.0005085968,0.003193591,0.001404807,0.01029583,0.9734535],"study_design_scores_gemma":[0.0001847693,0.0005354805,0.003646897,0.003812427,0.0009091915,0.004789237,0.00009663357,0.0004245244,0.004313603,0.001845121,0.9793879,0.00005414287],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003585446,0.9987263,0.0001292406,0.0001354458,0.00006431365,0.000003121071,0.00001984105,0.000004879711,0.000558233],"genre_scores_gemma":[0.002028615,0.9969648,0.0002122293,0.0002009829,0.0001187751,0.000005920837,0.00004287286,0.000001663741,0.0004241213],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001941065,"threshold_uncertainty_score":0.006493449,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2073922081","doi":"10.1053/j.seminoncol.2008.12.007","title":"Management of Early and Locally Advanced Cervical Cancer","year":2009,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Cervical cancer; Malignancy; Cancer; Primary treatment; Cervical carcinoma; Oncology; Primary cancer; Internal medicine; Intensive care medicine","authors":[{"name":"Lisa Barbera","is_ca":true},{"name":"Gillian Thomas","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.037623921247355,"gpt":0.4045031393347371,"spread":0.3668792180873821,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006025333,0.0007978947,0.001764905,0.001946301,0.0002345557,0.0008512565,0.001209043,0.0009227124,0.002681345],"category_scores_gemma":[0.00122971,0.000303252,0.0006760281,0.001577679,0.0004803716,0.001014685,0.000555777,0.001364874,0.0008692188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006425382,"about_ca_system_score_gemma":0.0009814752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002167585,"about_ca_topic_score_gemma":0.005557755,"domain_scores_codex":[0.9997446,0.00006376969,0.00004561698,0.00004118184,0.00008316081,0.00002155893],"domain_scores_gemma":[0.9996355,0.0002224104,0.00006368816,0.00000694606,0.00005219611,0.00001936457],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008150867,0.00004944623,0.000249427,0.02974048,0.0001350238,0.0002767192,0.00004091218,0.0003007114,0.0004707691,0.0006281777,0.01587875,0.9521481],"study_design_scores_gemma":[0.0001268578,0.0002996378,0.003942604,0.0358906,0.0009979202,0.005723569,0.0002470573,0.000240255,0.0005801218,0.001637524,0.9502664,0.00004746456],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005992723,0.9994739,0.00003895978,0.0000773923,0.00006930934,0.000002315243,0.00000534574,0.000001861211,0.0002710552],"genre_scores_gemma":[0.0007434378,0.9986998,0.0001140733,0.0001545522,0.00009743894,0.000003364971,0.00001511326,6.62683e-7,0.0001715918],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002681345,"threshold_uncertainty_score":0.008969963,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156946556","doi":"10.1053/sonc.2002.31672","title":"Radioembolization for hepatic metastases","year":2002,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Radiology; Nuclear medicine","authors":[{"name":"Milton J. Herba","is_ca":true},{"name":"Michael P. Thirlwell","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08558073659995405,"gpt":0.3146175871290862,"spread":0.2290368505291322,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002354798,0.000164265,0.0003702863,0.0005802366,0.0002602425,0.0002260034,0.0001867393,0.0002740264,0.003915964],"category_scores_gemma":[0.0008142053,0.00006818369,0.0002179698,0.0005235416,0.0002789954,0.0003428221,0.0002024361,0.0003202039,0.0009131596],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004043096,"about_ca_system_score_gemma":0.0003274375,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006711519,"about_ca_topic_score_gemma":0.0009586306,"domain_scores_codex":[0.9999387,0.00001565465,0.000004600783,0.000005573339,0.00001351371,0.00002187125],"domain_scores_gemma":[0.9998839,0.00005073126,0.00001735702,0.00001495162,0.000007294416,0.00002571528],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01004896,0.0004466063,0.0815016,0.0007707456,0.0002141829,0.01483212,0.0002962918,0.001332033,0.02791846,0.002147984,0.01204581,0.8484452],"study_design_scores_gemma":[0.001918658,0.01076101,0.659446,0.0003189448,0.0007779829,0.1564239,0.0004024162,0.00260057,0.04972656,0.008206138,0.109329,0.00008886297],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.8443268,0.09209552,0.005993497,0.008121309,0.0008009869,0.0001016824,0.0003000077,0.0002637289,0.04799641],"genre_scores_gemma":[0.9723969,0.0183454,0.001053168,0.0004450422,0.0008324694,0.00003219512,0.0001795881,0.00003571759,0.006679642],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.003915964,"threshold_uncertainty_score":0.01310021,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156093622","doi":"10.1053/j.seminoncol.2009.03.005","title":"Psychosocial Issues and Quality of Life","year":2009,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Psychosocial; Medicine; Generativity; Quality of life (healthcare); Psychological intervention; Gerontology; Compromise; Childhood cancer; Cancer; Developmental psychology; Psychiatry; Nursing; Psychology","authors":[{"name":"Christine Eiser","is_ca":false},{"name":"Anthony Penn","is_ca":false},{"name":"Ernest R. Katz","is_ca":false},{"name":"Ronald D. Barr","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1109861806948714,"gpt":0.489135716010319,"spread":0.3781495353154475,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006913784,0.0007922065,0.001542708,0.002174359,0.0002733414,0.0009500509,0.0005805684,0.0007439995,0.002748754],"category_scores_gemma":[0.001764424,0.0002531057,0.0007174693,0.003286697,0.0004959199,0.0008337123,0.0007430738,0.001278812,0.0003694353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007620255,"about_ca_system_score_gemma":0.001275793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002792468,"about_ca_topic_score_gemma":0.008399051,"domain_scores_codex":[0.9997124,0.00007708648,0.00005184703,0.00003654416,0.0001005373,0.00002152621],"domain_scores_gemma":[0.9992841,0.0004172595,0.0001668136,0.000009123481,0.00008392894,0.00003875052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006171683,0.00009536417,0.001876713,0.04015099,0.0005459377,0.0001034531,0.0001090641,0.0001589328,0.0001871677,0.0009101323,0.01806021,0.9377403],"study_design_scores_gemma":[0.0001315233,0.0003377931,0.04491641,0.1172363,0.003711303,0.002664105,0.00110594,0.000235662,0.0004092013,0.00304319,0.8261204,0.00008828776],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001708897,0.9991587,0.00001951185,0.0001850066,0.0001046186,0.000002932576,0.00001181293,0.000001095624,0.0003453849],"genre_scores_gemma":[0.001813711,0.9976729,0.00007218275,0.0001586975,0.0001031949,0.000007169774,0.00001755919,3.611963e-7,0.0001543558],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002792468,"threshold_uncertainty_score":0.009195507,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2051864325","doi":"10.1053/j.seminoncol.2009.07.008","title":"Colorectal Cancer in Young Adults","year":2009,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Disease; Colorectal cancer; Etiology; Population; Young adult; Stage (stratigraphy); Cancer; Presentation (obstetrics); Oncology; Internal medicine; Pediatrics; Gerontology; Intensive care medicine; Surgery","authors":[{"name":"Kevin Zbuk","is_ca":true},{"name":"Emma L. Sidebotham","is_ca":false},{"name":"Archie Bleyer","is_ca":false},{"name":"Michael P. LaQuaglia","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02743801909510224,"gpt":0.3945308383961305,"spread":0.3670928193010282,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006782134,0.0006168446,0.001945796,0.003368771,0.0001838978,0.0007078713,0.0003537509,0.0006387027,0.004454095],"category_scores_gemma":[0.002104428,0.0002951642,0.0008460125,0.004012151,0.0002936647,0.0008106364,0.0006944878,0.0005016042,0.0004905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006312179,"about_ca_system_score_gemma":0.001645088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004125202,"about_ca_topic_score_gemma":0.01446301,"domain_scores_codex":[0.9997085,0.000082206,0.00007918123,0.00003723267,0.00007021896,0.00002277677],"domain_scores_gemma":[0.9991537,0.0004502512,0.0002769501,0.00001137208,0.00006824574,0.00003947403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001921072,0.00003652178,0.001854733,0.145733,0.0007979084,0.0002592314,0.0001118654,0.00009134012,0.0004111127,0.0004673945,0.02370883,0.826336],"study_design_scores_gemma":[0.0003601139,0.0005396772,0.02953763,0.2564659,0.008459127,0.004520723,0.0005936277,0.0001202139,0.000552825,0.0008784782,0.697914,0.00005768763],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000174277,0.999284,0.00001195074,0.0001224785,0.00008699224,0.000005197094,0.00002426005,0.00000139372,0.0002894823],"genre_scores_gemma":[0.001447779,0.998044,0.00004755086,0.0002100719,0.00007345763,0.000006847288,0.00001955383,2.970864e-7,0.0001503603],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004454095,"threshold_uncertainty_score":0.01490045,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2053652371","doi":"10.1053/j.seminoncol.2013.12.008","title":"Genes and Pathology of Non-Small Cell Lung Carcinoma","year":2013,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Lung cancer; Adenocarcinoma; Context (archaeology); Histopathology; Pathology; Molecular pathology; Carcinoma; Lung; Pathological; Oncology; Cancer; Internal medicine; Bioinformatics; Gene; Biology; Genetics","authors":[{"name":"Shingo Sakashita","is_ca":true},{"name":"Mai Sakashita","is_ca":true},{"name":"Ming‐Sound Tsao","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02701633508221754,"gpt":0.3832285918759801,"spread":0.3562122567937626,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004110908,0.0007233012,0.001170294,0.001802318,0.0001794823,0.0008473772,0.0007753001,0.0008923851,0.002305138],"category_scores_gemma":[0.0006922243,0.0002739099,0.0004088861,0.001856143,0.0005641376,0.0009284149,0.00052951,0.001206423,0.001256458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006410552,"about_ca_system_score_gemma":0.001077227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001385168,"about_ca_topic_score_gemma":0.002618375,"domain_scores_codex":[0.9998465,0.00002415427,0.00002423822,0.00002821067,0.00005985263,0.00001711954],"domain_scores_gemma":[0.9997162,0.0001515456,0.00004489858,0.000008158507,0.00006058509,0.00001862567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005686103,0.00003505396,0.000395533,0.009692471,0.00009121661,0.0003043762,0.00003591674,0.0003913316,0.001517682,0.002192196,0.04152432,0.9437631],"study_design_scores_gemma":[0.00002250306,0.00004439958,0.001793132,0.00408,0.0002228615,0.002211706,0.00007429584,0.0001198306,0.0005229489,0.002739373,0.9881454,0.00002360127],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006972733,0.9989705,0.0000701621,0.0002246745,0.000155562,0.000001544007,0.00001268242,0.000004256434,0.0004909277],"genre_scores_gemma":[0.0005865484,0.998524,0.000101419,0.0001777667,0.0002026705,0.000001869955,0.00002386766,7.733931e-7,0.0003810807],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002305138,"threshold_uncertainty_score":0.00771147,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089445137","doi":"10.1053/j.seminoncol.2004.11.013","title":"Palliative radiation therapy","year":2005,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Palliative care; Cancer; Lung cancer; Population; Disease; Stereotactic radiation therapy; Surgery; Performance status; Oncology; Internal medicine","authors":[{"name":"André Konski","is_ca":false},{"name":"Steven J. Feigenberg","is_ca":false},{"name":"Edward Chow","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09286949844267094,"gpt":0.4563326392391604,"spread":0.3634631407964894,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002616327,0.0008566391,0.001355098,0.001377974,0.0002814404,0.0005576857,0.0006192954,0.0006126699,0.008735324],"category_scores_gemma":[0.0006345629,0.0002071212,0.0003821196,0.001418529,0.0003643208,0.0007971168,0.0006267796,0.001123611,0.003114518],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004490127,"about_ca_system_score_gemma":0.0006253312,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005027779,"about_ca_topic_score_gemma":0.001812777,"domain_scores_codex":[0.9998938,0.0000284552,0.00001416864,0.00002422772,0.00002809797,0.00001121946],"domain_scores_gemma":[0.9998604,0.00006393743,0.00002909443,0.000008241722,0.00002435235,0.00001399038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004751885,0.00002733211,0.00009734477,0.009755928,0.00005358532,0.0002359936,0.00003114745,0.0003088248,0.0009457316,0.001154801,0.03664685,0.9506949],"study_design_scores_gemma":[0.00004334645,0.0001171335,0.000977722,0.005346078,0.0001892205,0.005967839,0.00003750038,0.0001039485,0.0006414996,0.001369677,0.9851905,0.00001567183],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002054002,0.9945589,0.0003384943,0.0002223788,0.0004368332,0.000009820829,0.00002278013,0.00001662255,0.004188712],"genre_scores_gemma":[0.002927333,0.9920557,0.0004797004,0.0006491324,0.0004219729,0.00001772176,0.00008011684,0.000004343824,0.003363883],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008735324,"threshold_uncertainty_score":0.02922261,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2032836693","doi":"10.1053/j.seminoncol.2014.03.009","title":"Pharmacoeconomics of Cancer Therapies: Considerations With the Introduction of Biosimilars","year":2014,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Medicine; Pharmacoeconomics; Innovator; Health care; Risk analysis (engineering); Reimbursement; Product (mathematics); Intensive care medicine; Business","authors":[{"name":"David H. Henry","is_ca":false},{"name":"Carrie Turich Taylor","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03854655976674012,"gpt":0.4049752124438392,"spread":0.3664286526770991,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005243172,0.0008744585,0.00244713,0.003249273,0.0003832258,0.002865567,0.001534883,0.004044551,0.002683238],"category_scores_gemma":[0.009100207,0.0004675259,0.001474557,0.004363577,0.001483307,0.003904944,0.000864047,0.006141889,0.001149697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002699898,"about_ca_system_score_gemma":0.003583316,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002509037,"about_ca_topic_score_gemma":0.003531301,"domain_scores_codex":[0.9980805,0.0005828189,0.0002135996,0.0001717346,0.0008712292,0.0000802081],"domain_scores_gemma":[0.991655,0.005927623,0.0005617952,0.0001328559,0.001527171,0.0001955626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006430661,0.00007070921,0.000260603,0.01303347,0.0001999426,0.0002633949,0.0001118996,0.001407701,0.0005117002,0.03330074,0.04110727,0.9096682],"study_design_scores_gemma":[0.00002994747,0.0001048509,0.001070572,0.01211841,0.0001602909,0.001357068,0.0001650016,0.0005040303,0.000277399,0.0219758,0.9621919,0.00004460904],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008116331,0.9949443,0.0003160201,0.0033934,0.0003496005,0.000004453781,0.000009309552,0.000004810407,0.0008968697],"genre_scores_gemma":[0.0008263854,0.9960809,0.0006096964,0.001427265,0.0006907794,0.00001085591,0.00001122923,0.000002883808,0.0003401063],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005243172,"threshold_uncertainty_score":0.02772886,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1984740505","doi":"10.1053/sonc.2002.30143","title":"Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma","year":2002,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Mantle cell lymphoma; Autologous stem-cell transplantation; Transplantation; Surgery; Cyclophosphamide; Internal medicine; Vincristine; Chemoimmunotherapy; Oncology; Debulking; Chemotherapy; Lymphoma; Cancer; Ovarian cancer","authors":[{"name":"Joy Mangel","is_ca":true},{"name":"Rena Buckstein","is_ca":true},{"name":"Kevin Imrie","is_ca":true},{"name":"David Spaner","is_ca":true},{"name":"Michael Crump","is_ca":true},{"name":"Kirsty A. Tompkins","is_ca":true},{"name":"Marciano D. Reis","is_ca":true},{"name":"Bayardo Perez‐Ordoñez","is_ca":true},{"name":"Sanjeev Deodhare","is_ca":true},{"name":"Robert Romans","is_ca":true},{"name":"Nancy Pennell","is_ca":true},{"name":"Jean B. Robinson","is_ca":true},{"name":"Karen Hewitt","is_ca":true},{"name":"P. Richardson","is_ca":true},{"name":"Ana Lima","is_ca":true},{"name":"Peggy Pavlin","is_ca":true},{"name":"Neil L. Berinstein","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01603735085388839,"gpt":0.2652146358125071,"spread":0.2491772849586188,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007943087,0.0003304777,0.0006703441,0.0005171842,0.0005885827,0.0003820325,0.0004642799,0.001259478,0.000857097],"category_scores_gemma":[0.001430934,0.0001736868,0.0006129979,0.0002411741,0.0003563282,0.0005195987,0.0002963821,0.001501302,0.0002827025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005785716,"about_ca_system_score_gemma":0.0003348023,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007461556,"about_ca_topic_score_gemma":0.001289719,"domain_scores_codex":[0.999743,0.00009129322,0.00002907326,0.00002444206,0.00003437154,0.00007779132],"domain_scores_gemma":[0.9995905,0.0002180588,0.00005961283,0.00004945269,0.00001894259,0.00006347084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"case_report","study_design_scores_codex":[0.06624809,0.01151794,0.07181557,0.0008177032,0.001189272,0.1323087,0.000540758,0.01584741,0.07808606,0.005726812,0.02130737,0.5945943],"study_design_scores_gemma":[0.01735139,0.08468978,0.4238543,0.0003496087,0.001932298,0.257846,0.0003011178,0.03208499,0.08969118,0.01220696,0.07942793,0.0002645441],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.958501,0.01402854,0.003824414,0.003911873,0.0008244072,0.0002780787,0.0001263004,0.0002430632,0.01826235],"genre_scores_gemma":[0.996077,0.0009022707,0.0008376788,0.0006140465,0.000392346,0.00005085823,0.0001032433,0.00001249971,0.00101012],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001259478,"threshold_uncertainty_score":0.004200757,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2044362858","doi":"10.1053/j.seminoncol.2009.10.010","title":"Evaluating Temsirolimus Activity in Multiple Tumors: A Review of Clinical Trials","year":2009,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Occupational Cancer Research Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Temsirolimus; Medicine; Mantle cell lymphoma; Clinical trial; Oncology; Lymphoma; Sirolimus; Internal medicine; Cancer research; PI3K/AKT/mTOR pathway; Cancer; Discovery and development of mTOR inhibitors; Signal transduction; Biology","authors":[{"name":"Janet Dancey","is_ca":true},{"name":"Rafael E. Curiel","is_ca":false},{"name":"J. Purvis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3830836845941913,"gpt":0.596782249862561,"spread":0.2136985652683697,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002054096,0.001148242,0.00470753,0.001836031,0.0002103473,0.001370953,0.001569718,0.001021417,0.002252728],"category_scores_gemma":[0.002488732,0.0004088051,0.001503215,0.002508189,0.0003846993,0.001199963,0.0004482977,0.001472361,0.0007281465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009641664,"about_ca_system_score_gemma":0.001327683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001059087,"about_ca_topic_score_gemma":0.00334681,"domain_scores_codex":[0.9996184,0.00009198723,0.0000962237,0.00007519065,0.00009304847,0.00002510037],"domain_scores_gemma":[0.9985687,0.0009220658,0.0002173151,0.00002795248,0.0001926918,0.00007121992],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0009750548,0.0001018109,0.0003729131,0.02469058,0.0008448869,0.0001718899,0.00003610989,0.0006381425,0.001686499,0.0005800789,0.01908999,0.9508121],"study_design_scores_gemma":[0.002802256,0.003198145,0.006671068,0.03075876,0.01070537,0.003862953,0.0001608904,0.0009971194,0.003148426,0.002649197,0.9348897,0.0001561661],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003512288,0.9987662,0.0001612993,0.0002439903,0.00008893914,0.00001752275,0.00005246915,0.00000808151,0.00031036],"genre_scores_gemma":[0.002398441,0.9955983,0.0007002032,0.0006758058,0.0001314716,0.00003429249,0.00013005,0.000006111144,0.0003251974],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00470753,"threshold_uncertainty_score":0.01086324,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045470396","doi":"10.1053/j.seminoncol.2012.09.004","title":"Selective T-Cell Depletion for Haplotype-Mismatched Allogeneic Stem Cell Transplantation","year":2012,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Medicine; Transplantation; Stem cell; Haplotype; Cell; Immunology; Cancer research; Genetics; Internal medicine; Gene; Biology; Genotype","authors":[{"name":"Jean-Philippe Bastien","is_ca":true},{"name":"Jean Roy","is_ca":true},{"name":"Denis‐Claude Roy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05291611413076512,"gpt":0.3530624821674423,"spread":0.3001463680366772,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004662994,0.0007500777,0.001139626,0.0009246568,0.0001455575,0.0005816261,0.0008344595,0.0005684943,0.002125784],"category_scores_gemma":[0.0003302113,0.0001679601,0.0002890051,0.0008108582,0.0003829335,0.0006277374,0.000476021,0.001185541,0.001510955],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003321768,"about_ca_system_score_gemma":0.0004890115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003486171,"about_ca_topic_score_gemma":0.001004469,"domain_scores_codex":[0.999915,0.0000133125,0.00001160764,0.00001597366,0.00003177139,0.00001236914],"domain_scores_gemma":[0.9998835,0.0000570908,0.00001976616,0.000004631901,0.0000213521,0.00001358193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001255345,0.00009462846,0.0001430609,0.006518455,0.00006010713,0.0001600337,0.00001720943,0.0002976854,0.005586531,0.001804405,0.01694456,0.9682478],"study_design_scores_gemma":[0.0001043419,0.0002885697,0.001300288,0.002218145,0.0002390106,0.002156679,0.0000376046,0.0001772602,0.00510087,0.001760143,0.9865896,0.00002752072],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003853833,0.9978635,0.0003723666,0.0001602333,0.0002239013,0.00000694509,0.00002071731,0.00001213657,0.0009549018],"genre_scores_gemma":[0.002048858,0.9962675,0.0003616285,0.0002780348,0.0001742855,0.00001428813,0.00005189107,0.000003053588,0.0008004576],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002125784,"threshold_uncertainty_score":0.00711143,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2033893059","doi":"10.1053/j.seminoncol.2003.12.021","title":"Targeted molecules in small cell lung cancer","year":2004,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Imatinib mesylate; Cancer research; Tyrosine kinase; Targeted therapy; Cancer; Immunoconjugate; Clinical trial; Imatinib; Immunology; Oncology; Antibody; Pathology; Internal medicine; Receptor; Monoclonal antibody","authors":[{"name":"Nevin Murray","is_ca":true},{"name":"Ravi Salgia","is_ca":false},{"name":"Frank V. Fossella","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04207325589161267,"gpt":0.4411456812393817,"spread":0.3990724253477691,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009308946,0.001187758,0.002496929,0.002777497,0.0003138103,0.001267791,0.0009267626,0.001490253,0.004041429],"category_scores_gemma":[0.0008241007,0.0004067198,0.0006280009,0.003005544,0.0006886727,0.001794058,0.0006785855,0.001882949,0.002263067],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009850153,"about_ca_system_score_gemma":0.001250878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001270049,"about_ca_topic_score_gemma":0.003341266,"domain_scores_codex":[0.9998232,0.00003735474,0.00002841316,0.00003020916,0.00005882417,0.00002209692],"domain_scores_gemma":[0.9996721,0.000177335,0.00005046181,0.00001208117,0.00006100263,0.00002711783],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002021444,0.000110378,0.0001263418,0.01984523,0.0001565582,0.0002837492,0.00004604055,0.0004130218,0.00306233,0.002537614,0.0499428,0.9232738],"study_design_scores_gemma":[0.00009489592,0.000209135,0.0005580903,0.003076194,0.000317351,0.001119885,0.00004078275,0.00007665143,0.000851044,0.0009588578,0.9926797,0.00001748518],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000632056,0.9989547,0.00008158549,0.0001723566,0.000247995,0.000005433146,0.000009568636,0.000005840081,0.0004593265],"genre_scores_gemma":[0.0004960464,0.9982933,0.0001146502,0.0002399483,0.0001669685,0.000008425641,0.00001477787,9.066152e-7,0.0006648582],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004041429,"threshold_uncertainty_score":0.01351994,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1991788040","doi":"10.1053/j.seminoncol.2007.10.006","title":"Clinical Benefits and Considerations of Bisphosphonate Treatment in Metastatic Bone Disease","year":2007,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Zoledronic acid; Prostate cancer; Breast cancer; Oncology; Multiple myeloma; Internal medicine; Bone pain; Bone disease; N-terminal telopeptide; Bone resorption; Bisphosphonate; Osteoporosis; Cancer; Alkaline phosphatase; Osteocalcin","authors":[{"name":"Fred Saad","is_ca":true},{"name":"Allan Lipton","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1722484196294169,"gpt":0.4989749170315599,"spread":0.3267264974021431,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001306871,0.000718674,0.002140408,0.002214563,0.0002938184,0.001298071,0.001062512,0.001600689,0.003193658],"category_scores_gemma":[0.001887175,0.0003320862,0.0007140838,0.002240932,0.0006909434,0.00111413,0.0004919445,0.002335108,0.001151808],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008872324,"about_ca_system_score_gemma":0.001162048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00147729,"about_ca_topic_score_gemma":0.005122827,"domain_scores_codex":[0.9995808,0.0001002429,0.00007617778,0.00004678154,0.0001706854,0.00002541451],"domain_scores_gemma":[0.9991497,0.0005620061,0.0001271321,0.0000117854,0.000115686,0.0000337261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002560051,0.00007352864,0.0003064029,0.02155997,0.0002172239,0.0005551805,0.0000532649,0.0004409279,0.0008327958,0.004156616,0.03450971,0.9370384],"study_design_scores_gemma":[0.0001717888,0.0002138176,0.00240913,0.01543956,0.0007331315,0.004784117,0.0001403282,0.0002476922,0.0004051549,0.004378056,0.9710374,0.00003987212],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005285852,0.9990403,0.00003490231,0.0003431324,0.0001259035,0.00000138331,0.000005543803,0.000001664336,0.0003942068],"genre_scores_gemma":[0.0007738218,0.9981554,0.0001499137,0.000419784,0.0002673931,0.000003104224,0.00001031249,7.074208e-7,0.0002195109],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003193658,"threshold_uncertainty_score":0.01068383,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2765724600","doi":"10.1053/j.seminoncol.2017.10.009","title":"Management of stage III non–small cell lung cancer","year":2017,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Context (archaeology); Malignancy; Immunotherapy; Lung cancer; Disease; Intensive care medicine; Stage (stratigraphy); Cancer; Radiation therapy; Oncology; Surgery; Internal medicine","authors":[{"name":"Samer Tabchi","is_ca":true},{"name":"Elie Kassouf","is_ca":true},{"name":"Elie Rassy","is_ca":false},{"name":"Hampig Raphaël Kourié","is_ca":false},{"name":"Jocelyne Martin","is_ca":true},{"name":"Marie‐Pierre Campeau","is_ca":true},{"name":"Mustapha Tehfé","is_ca":true},{"name":"Normand Blais","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05417943617264763,"gpt":0.43365465582967,"spread":0.3794752196570224,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005032542,0.0006236453,0.001418929,0.001389681,0.0002236261,0.0009501418,0.001052144,0.0007780789,0.001995713],"category_scores_gemma":[0.001059398,0.0002150995,0.000762756,0.0009436969,0.0004043558,0.0008839353,0.0006179956,0.001330988,0.0006865917],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005650052,"about_ca_system_score_gemma":0.0009162386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001452393,"about_ca_topic_score_gemma":0.004228822,"domain_scores_codex":[0.9997588,0.00005319896,0.00004399662,0.00004285432,0.00007879012,0.00002246431],"domain_scores_gemma":[0.9997215,0.0001541195,0.0000560588,0.000005435605,0.00004492949,0.00001800969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005844692,0.00003936129,0.0003597528,0.02412737,0.0001645451,0.0002202346,0.00003401158,0.0002929878,0.0004796479,0.0007957826,0.01904711,0.9543808],"study_design_scores_gemma":[0.00009417034,0.0002280693,0.004675164,0.02971711,0.0009165914,0.005001664,0.0001784869,0.0002683295,0.0004493837,0.002437796,0.9559807,0.0000525376],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006407899,0.9994191,0.00004209852,0.0001135755,0.00009264152,0.000002205218,0.000006187955,0.000001934418,0.0002580987],"genre_scores_gemma":[0.001047108,0.9981654,0.0001223332,0.000268542,0.00019463,0.000003773508,0.00002377072,7.693387e-7,0.0001736273],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001995713,"threshold_uncertainty_score":0.006676316,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2074609728","doi":"10.1053/j.seminoncol.2007.03.008","title":"Local Management of Adult Soft Tissue Sarcomas","year":2007,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Radiation therapy; Sarcoma; Soft tissue; Adjuvant radiotherapy; Trunk; Surgery; Soft tissue sarcoma; Adjuvant; Adjuvant therapy; Radiology; Oncology; Chemotherapy; Pathology","authors":[{"name":"Carol J. Swallow","is_ca":true},{"name":"Charles Catton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04790951265337286,"gpt":0.4122803651611181,"spread":0.3643708525077453,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004532753,0.0007210654,0.001616314,0.001704968,0.0002281677,0.0007277154,0.001045003,0.0007016326,0.002634494],"category_scores_gemma":[0.0007293295,0.0002580433,0.0005687325,0.001448023,0.0004569362,0.0009741914,0.000500194,0.001106787,0.001147232],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004281077,"about_ca_system_score_gemma":0.000526513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008688787,"about_ca_topic_score_gemma":0.002886847,"domain_scores_codex":[0.9997967,0.00004627094,0.00003402905,0.00003768275,0.0000667994,0.00001856566],"domain_scores_gemma":[0.9996947,0.0001682361,0.00006394354,0.000008784588,0.00004373214,0.00002053768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005943134,0.00005332992,0.0002245462,0.01450184,0.00008768016,0.0005225618,0.00003709214,0.0004028621,0.0009081074,0.0004670072,0.01238939,0.9703461],"study_design_scores_gemma":[0.0001373539,0.0005091021,0.004839194,0.01892141,0.0008493208,0.02207986,0.0002520407,0.0003780722,0.001618747,0.001541546,0.9488139,0.00005946597],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001871331,0.9990702,0.0001249764,0.00007444729,0.00007015152,0.000003034468,0.000005962429,0.000005456207,0.0004586302],"genre_scores_gemma":[0.001884086,0.9970901,0.000227967,0.0002085589,0.0001418347,0.000005366197,0.00002511229,0.000001985711,0.0004150128],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002634494,"threshold_uncertainty_score":0.008813262,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3010479561","doi":"10.1053/j.seminoncol.2020.02.007","title":"Current and coming challenges in the management of the survivorship population","year":2020,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Survivorship curve; Medicine; Psychosocial; Childhood cancer; Epidemiology; Population; Cancer; Gerontology; Cancer survivorship; Pediatrics; Demography; Environmental health; Psychiatry; Pathology; Internal medicine","authors":[{"name":"Eric J. Chow","is_ca":false},{"name":"Kirsten K. Ness","is_ca":false},{"name":"Gregory T. Armstrong","is_ca":false},{"name":"Nickhill Bhakta","is_ca":false},{"name":"Jennifer M. Yeh","is_ca":false},{"name":"Smita Bhatia","is_ca":false},{"name":"Wendy Landier","is_ca":false},{"name":"Louis S. Constine","is_ca":false},{"name":"Melissa M. Hudson","is_ca":false},{"name":"Paul C. Nathan","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1595619280799779,"gpt":0.4339071313693772,"spread":0.2743452032893993,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041479,0.0006961796,0.002052207,0.001939764,0.0005534154,0.002464757,0.001263414,0.002360879,0.004386641],"category_scores_gemma":[0.005910066,0.0002970489,0.0009439861,0.003172931,0.001236476,0.003211362,0.001519935,0.00413453,0.001021454],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002202685,"about_ca_system_score_gemma":0.00563383,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004788198,"about_ca_topic_score_gemma":0.01280724,"domain_scores_codex":[0.9991197,0.0003105949,0.0001252815,0.0001007918,0.0002582129,0.00008545433],"domain_scores_gemma":[0.994136,0.004104841,0.0004684291,0.00005114113,0.0008235111,0.0004159686],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006731266,0.00005481234,0.0004824264,0.02367962,0.000130878,0.0001196718,0.0001667279,0.000347812,0.0001703313,0.00608797,0.04309288,0.9255996],"study_design_scores_gemma":[0.00004963647,0.0001694117,0.003479253,0.06175072,0.0004403643,0.001113763,0.00120033,0.0002743212,0.0001007603,0.009292214,0.9220651,0.00006404083],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004477585,0.9973181,0.00003699481,0.002155896,0.0002430242,0.00000113292,0.000006478284,0.000002412054,0.0001911159],"genre_scores_gemma":[0.0005321348,0.9980826,0.0001099297,0.000756812,0.0004096163,0.000003583947,0.00001292164,7.776158e-7,0.00009164563],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004788198,"threshold_uncertainty_score":0.02193648,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062119453","doi":"10.1053/j.seminoncol.2013.01.001","title":"Exercise Therapy as Treatment for Cardiovascular and Oncologic Disease After a Diagnosis of Early-Stage Cancer","year":2013,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Cancer; Disease; Adjuvant therapy; Stage (stratigraphy); Internal medicine; Intensive care medicine; Oncology","authors":[{"name":"Jessica M. Scott","is_ca":false},{"name":"Graeme J. Koelwyn","is_ca":true},{"name":"Whitney Hornsby","is_ca":false},{"name":"Michel G. Khouri","is_ca":false},{"name":"Jeffrey Peppercorn","is_ca":false},{"name":"Pamela S. Douglas","is_ca":false},{"name":"Lee W. Jones","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07458153917372895,"gpt":0.3985226177539175,"spread":0.3239410785801886,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003881508,0.0006810929,0.001668643,0.001382872,0.0001773314,0.0006186312,0.0007287112,0.0007291349,0.002516421],"category_scores_gemma":[0.000599543,0.0001999997,0.0006262921,0.001210813,0.0003083022,0.000555413,0.0004145468,0.00142143,0.0007636655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003608414,"about_ca_system_score_gemma":0.0006263488,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001202608,"about_ca_topic_score_gemma":0.00361774,"domain_scores_codex":[0.9998881,0.00002000331,0.0000216707,0.00002257247,0.0000372057,0.00001046359],"domain_scores_gemma":[0.9997223,0.0001757729,0.0000464695,0.000005117296,0.00003636294,0.00001400931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001470784,0.0001422613,0.0002905365,0.02896553,0.0002875054,0.0001696664,0.00003594508,0.0002625705,0.0009625474,0.001020055,0.01062023,0.9570962],"study_design_scores_gemma":[0.0002513446,0.0006108806,0.007002802,0.03264824,0.001665565,0.003091221,0.0002060479,0.0003086936,0.001036306,0.002665096,0.9504486,0.00006521238],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001039031,0.9994476,0.00003216982,0.00007226173,0.0000776848,0.00000288883,0.000007973226,0.000001796697,0.0002537011],"genre_scores_gemma":[0.0009279097,0.9985613,0.00009967353,0.0001161433,0.0001011697,0.00000428488,0.00001673038,6.445664e-7,0.0001720951],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002516421,"threshold_uncertainty_score":0.008418262,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1986647178","doi":"10.1016/s0093-7754(03)00171-4","title":"Treatment of cancer-related hypercalcemia: The role of gallium nitrate","year":2003,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Calcitonin; Bone resorption; Internal medicine; Endocrinology","authors":[{"name":"Brian Leyland‐Jones","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04123986567245706,"gpt":0.4119549617516539,"spread":0.3707150960791968,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005764694,0.0008585918,0.002605191,0.001408693,0.0002242656,0.0008455769,0.001177475,0.001215449,0.001918908],"category_scores_gemma":[0.0005481588,0.0002594529,0.0007726277,0.001780101,0.0005762505,0.0008321615,0.000519342,0.00195483,0.001014929],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006089061,"about_ca_system_score_gemma":0.0009077793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001904854,"about_ca_topic_score_gemma":0.004280614,"domain_scores_codex":[0.9998287,0.00003773477,0.0000249491,0.00003222231,0.00005897464,0.00001736805],"domain_scores_gemma":[0.9997593,0.0001262102,0.00004682337,0.000007493453,0.00004052939,0.00001968195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004141513,0.0001719988,0.0001847329,0.01166618,0.0001806958,0.0003931049,0.00004940798,0.0003600609,0.002713354,0.001395921,0.01957665,0.9628937],"study_design_scores_gemma":[0.0004419788,0.0006862406,0.002423463,0.004871553,0.0005898356,0.004368603,0.0001258823,0.0003098611,0.002134828,0.002470608,0.9815251,0.00005199612],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001813285,0.9990331,0.00008491881,0.0002257128,0.0001112635,0.000003152427,0.000006235696,0.000005193451,0.0003491176],"genre_scores_gemma":[0.001182162,0.9979558,0.0001832703,0.0002434845,0.0001087636,0.000004654636,0.00001404714,0.000001772148,0.0003060409],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002605191,"threshold_uncertainty_score":0.00641942,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2029030461","doi":"10.1016/s0093-7754(01)90065-x","title":"Temozolomide for recurrent high-grade glioma","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Temozolomide; Medicine; Anaplastic astrocytoma; Oncology; Glioma; Quality of life (healthcare); Internal medicine; Procarbazine; Lomustine; Progression-free survival; Clinical trial; Dacarbazine; Astrocytoma; Surgery; Chemotherapy; Vincristine; Cancer research","authors":[{"name":"D. Macdonald","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06659751042198406,"gpt":0.4115713583895171,"spread":0.3449738479675331,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002919431,0.0004898511,0.001075646,0.0009225968,0.0001264696,0.0003136326,0.0006039491,0.0003155822,0.001927026],"category_scores_gemma":[0.0004009091,0.0001259323,0.0003069821,0.001347776,0.0001614158,0.0004527043,0.0002014458,0.0004900934,0.0007773764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003943135,"about_ca_system_score_gemma":0.0005180306,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001768549,"about_ca_topic_score_gemma":0.0056466,"domain_scores_codex":[0.9999397,0.00001228157,0.00001422759,0.0000110974,0.00001690561,0.000005778588],"domain_scores_gemma":[0.9998935,0.00004097367,0.00003357839,0.000004776948,0.00001803273,0.00000906585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001910229,0.00004791206,0.0001719695,0.007703323,0.0001341878,0.0002849921,0.00002558841,0.0002325528,0.001418762,0.0003096978,0.01831392,0.971166],"study_design_scores_gemma":[0.0003110958,0.0009210539,0.005165112,0.002709706,0.001063119,0.006678831,0.00007362477,0.0002863987,0.002898729,0.0005889421,0.9792716,0.00003172511],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001084474,0.9971632,0.0001846399,0.0002069905,0.0001767821,0.00000917435,0.00003617773,0.00001513869,0.001123356],"genre_scores_gemma":[0.005264171,0.9925921,0.0002844489,0.000261291,0.0001252489,0.00001022604,0.00007666316,0.000003127244,0.001382757],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001927026,"threshold_uncertainty_score":0.00644654,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988586595","doi":"10.1053/sonc.2003.50017","title":"Thoracic radiotherapy for limited-stage small cell lung cancer: Issues of timing, volumes, dose, and fractionation","year":2003,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Radiation therapy; Medicine; Chemotherapy; Dose fractionation; Randomized controlled trial; Oncology; Lung cancer; Stage (stratigraphy); Internal medicine; Surgery","authors":[{"name":"Sara Erridge","is_ca":true},{"name":"Nevin Murray","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08208530181503791,"gpt":0.4927384745917523,"spread":0.4106531727767144,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001615083,0.000715985,0.002698976,0.00112529,0.0002471344,0.0007397315,0.001295103,0.0008955478,0.002063915],"category_scores_gemma":[0.001482663,0.0002955133,0.0006359812,0.002616176,0.0005656376,0.0009020112,0.0003779707,0.001097908,0.0007671289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009372266,"about_ca_system_score_gemma":0.001578976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002790584,"about_ca_topic_score_gemma":0.008070012,"domain_scores_codex":[0.9996929,0.00008983143,0.00004840722,0.0000499605,0.0001004533,0.00001845495],"domain_scores_gemma":[0.9993748,0.0004207671,0.00008680887,0.0000154903,0.00008539027,0.00001671761],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001969191,0.00004966843,0.0002748879,0.02137568,0.0001654814,0.0001433933,0.00004616764,0.0004087764,0.001126963,0.0008651023,0.008981416,0.9663657],"study_design_scores_gemma":[0.0002821241,0.0008905329,0.006067977,0.01710196,0.001513007,0.00452018,0.0002867563,0.000193519,0.001426989,0.002532686,0.9651359,0.00004842762],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008950551,0.9995306,0.00003934434,0.0001002004,0.00004795085,0.00000185887,0.000002669143,0.000001465165,0.0001864852],"genre_scores_gemma":[0.0005648348,0.9990155,0.0001059102,0.000116786,0.00005203113,0.000003382575,0.000005325904,5.802621e-7,0.0001356447],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002790584,"threshold_uncertainty_score":0.008541465,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2063044382","doi":"10.1053/sonc.2002.37418","title":"Treatment of bone complications in advanced prostate cancer: Rationale for bisphosphonate use and results of a phase III trial with zoledronic acid","year":2002,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Zoledronic acid; Medicine; Prostate cancer; Bisphosphonate; Bone pain; Bone disease; Cancer; Internal medicine; Oncology; Surgery; Urology; Osteoporosis","authors":[{"name":"Fred Saad","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08148374553096663,"gpt":0.4323332133059353,"spread":0.3508494677749687,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001182421,0.0006927407,0.003138653,0.0009787257,0.0001697351,0.0006927536,0.001087975,0.0009551335,0.00177322],"category_scores_gemma":[0.0009812205,0.000251957,0.001315491,0.001513532,0.0002949234,0.0004020143,0.0002144632,0.001326361,0.0004030014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006060896,"about_ca_system_score_gemma":0.001192781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001564973,"about_ca_topic_score_gemma":0.005107021,"domain_scores_codex":[0.9997515,0.00006489048,0.00004814045,0.0000424949,0.0000736552,0.00001931359],"domain_scores_gemma":[0.9995102,0.0003122714,0.00008536796,0.00001092956,0.00005639583,0.00002490175],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002614805,0.0002466083,0.0005196968,0.03919754,0.001287894,0.0002468695,0.00004343855,0.0004956821,0.001865728,0.0007711381,0.01306321,0.9396474],"study_design_scores_gemma":[0.01835697,0.009611536,0.0185913,0.02954572,0.01624044,0.00725229,0.0002988488,0.0008664674,0.003866689,0.002918609,0.8923125,0.0001386856],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008115894,0.9984972,0.00006966911,0.0001968556,0.00008497968,0.00001862316,0.00003047042,0.00000480561,0.0002858047],"genre_scores_gemma":[0.004795499,0.9938544,0.0003382723,0.0005862043,0.00009760898,0.0000230436,0.00006763975,0.000002096086,0.0002352537],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003138653,"threshold_uncertainty_score":0.006253302,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3022810005","doi":"10.1016/s0093-7754(01)90138-1","title":"Surveillance for hepatocellular carcinoma","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Cirrhosis; Hepatitis B; Randomized controlled trial; Internal medicine; Intensive care medicine","authors":[{"name":"Morris Sherman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1290042608533236,"gpt":0.3658405095273251,"spread":0.2368362486740015,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008837685,0.0008205437,0.001451213,0.002815262,0.0002366456,0.0005887328,0.0006846847,0.001260091,0.005465412],"category_scores_gemma":[0.001809834,0.0001737844,0.0006140057,0.002489626,0.0003959308,0.0009702033,0.0005371857,0.000851121,0.002900259],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005234964,"about_ca_system_score_gemma":0.001023071,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001806971,"about_ca_topic_score_gemma":0.002885648,"domain_scores_codex":[0.9995453,0.000148569,0.00006425942,0.00007224199,0.0001390632,0.00003060984],"domain_scores_gemma":[0.9993606,0.0002868216,0.0001421498,0.00003538426,0.0001239019,0.00005109971],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005594514,0.00003384021,0.0005375271,0.01287531,0.0001227947,0.0001531749,0.00005092445,0.00009266008,0.0004163045,0.001159899,0.03514135,0.9493603],"study_design_scores_gemma":[0.00006472361,0.0001817508,0.005475926,0.0121066,0.0003159262,0.004964917,0.00009128397,0.00007119339,0.000407089,0.001633637,0.9746653,0.0000216179],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001442273,0.9968839,0.0001286981,0.0002908414,0.0002338676,0.00001103075,0.00002843791,0.000008597162,0.002270323],"genre_scores_gemma":[0.001676435,0.9961831,0.0002481215,0.000481791,0.0002390277,0.00001873015,0.00008034634,0.000001722105,0.001070567],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005465412,"threshold_uncertainty_score":0.01828367,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116041676","doi":"10.1053/j.seminoncol.2009.07.007","title":"The Adolescence of Young Adult Oncology","year":2009,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Subspecialty; Oncofertility; Medicine; Oncology; Population; Medical education; MEDLINE; Family medicine; Internal medicine; Public relations; Fertility preservation; Political science; Fertility","authors":[{"name":"Karen Albritton","is_ca":false},{"name":"Ronald D. Barr","is_ca":true},{"name":"Archie Bleyer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01837018021044158,"gpt":0.3581560821907117,"spread":0.3397859019802701,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013848,0.00013422,0.0002742873,0.0008158335,0.004189179,0.004048896,0.000289397,0.0009363868,0.003921855],"category_scores_gemma":[0.004160527,0.0002145387,0.0001798206,0.0007848866,0.001565588,0.002419494,0.002401487,0.001858551,0.0003098108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00242753,"about_ca_system_score_gemma":0.00639083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02021167,"about_ca_topic_score_gemma":0.06850345,"domain_scores_codex":[0.9993739,0.0002333228,0.00002538231,0.00003016715,0.00006796962,0.0002693188],"domain_scores_gemma":[0.9977436,0.0005171443,0.000294221,0.00003837198,0.0002569343,0.0011497],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0001377026,0.0006236748,0.3824797,0.0003942396,0.00002817593,0.004914829,0.3281543,0.0001175589,0.001109171,0.06556325,0.06700057,0.1494768],"study_design_scores_gemma":[0.00001337243,0.0001125609,0.2689115,0.001136017,0.00002569169,0.002195638,0.4105001,0.00006454635,0.0003293593,0.007131992,0.3095536,0.00002566963],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7329021,0.04194418,0.0003894123,0.08746506,0.002151744,0.00008465331,0.0004233251,0.00003604689,0.1346035],"genre_scores_gemma":[0.9749423,0.01388721,0.0001167058,0.003292793,0.0002075317,0.00004154856,0.00009242916,0.00001398584,0.007405564],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.02021167,"threshold_uncertainty_score":0.04018801,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2087324461","doi":"10.1053/j.seminoncol.2014.04.007","title":"Pharmacological Regulation of Platelet Factors That Influence Tumor Angiogenesis","year":2014,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Angiogenesis; Medicine; Platelet; Metastasis; Hemostasis; Cancer research; Neovascularization; Mechanism (biology); Pathological; Cancer; Immunology; Pharmacology; Internal medicine","authors":[{"name":"Mengjie Yan","is_ca":true},{"name":"Gabriela Lesyk","is_ca":true},{"name":"Aneta Radziwon‐Balicka","is_ca":true},{"name":"Paul Jurasz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03620789227325197,"gpt":0.3634344828822936,"spread":0.3272265906090416,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004800981,0.000905657,0.001066056,0.001073509,0.0001918862,0.0008645444,0.0008057058,0.0009378626,0.001617899],"category_scores_gemma":[0.0004582941,0.0002994915,0.0004238538,0.001202238,0.0004914189,0.0007151322,0.0005123224,0.001975219,0.001249744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004945851,"about_ca_system_score_gemma":0.0004953676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004459598,"about_ca_topic_score_gemma":0.0007170793,"domain_scores_codex":[0.9998665,0.00001973295,0.00001657612,0.00002198368,0.00005397939,0.00002118784],"domain_scores_gemma":[0.9998875,0.00005065674,0.00001996584,0.000005709437,0.00002155961,0.00001451296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002410996,0.00017953,0.0002529371,0.009087395,0.0001275444,0.0004630968,0.0000445047,0.0006752196,0.01588899,0.005748674,0.02683922,0.9404518],"study_design_scores_gemma":[0.0001400393,0.0003088427,0.001543777,0.001219544,0.0002580388,0.00184468,0.00004414861,0.0003269884,0.008672312,0.003238763,0.9823631,0.00003973369],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005763478,0.996619,0.0006132438,0.0003144399,0.000293666,0.00001323466,0.00003176054,0.00001834901,0.001519963],"genre_scores_gemma":[0.00348389,0.9941376,0.0005932369,0.0003280076,0.0002874676,0.00002626836,0.00006978426,0.00000385982,0.001069849],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001617899,"threshold_uncertainty_score":0.005412459,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2127462608","doi":"10.1053/j.seminoncol.2004.07.020","title":"Maximizing clinical benefit with trastuzumab","year":2004,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Trastuzumab; Medicine; Vinorelbine; Oncology; Metastatic breast cancer; Internal medicine; Taxane; Capecitabine; Breast cancer; Chemotherapy; Gemcitabine; Clinical trial; Cancer; Colorectal cancer","authors":[{"name":"Richard H. Bell","is_ca":false},{"name":"Shail Verma","is_ca":true},{"name":"Michael Untch","is_ca":false},{"name":"David Cameron","is_ca":false},{"name":"Ian Smith","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1762313080300225,"gpt":0.5363274342574647,"spread":0.3600961262274421,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007805697,0.001076521,0.002016573,0.001346371,0.0001754231,0.0008587321,0.0007462128,0.0009830606,0.004589795],"category_scores_gemma":[0.001210641,0.0002615866,0.0004128707,0.00141195,0.0004275874,0.001224106,0.0005522033,0.001584735,0.001279965],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009720682,"about_ca_system_score_gemma":0.0007263225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005150911,"about_ca_topic_score_gemma":0.001702961,"domain_scores_codex":[0.9997851,0.00006200468,0.00003218854,0.00003313707,0.0000623674,0.00002527206],"domain_scores_gemma":[0.9996291,0.000251404,0.000060078,0.00001105526,0.00003301136,0.00001529175],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002263628,0.00006397857,0.00009368095,0.007417385,0.000131009,0.0001585623,0.00002100642,0.0004883896,0.0009574887,0.002769774,0.03185713,0.9558152],"study_design_scores_gemma":[0.0003304556,0.0002979087,0.001143997,0.005455143,0.0005685554,0.001701175,0.00003720804,0.0002796272,0.001445208,0.004474872,0.9842444,0.00002139751],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002109978,0.9972108,0.0001988421,0.0007265542,0.0002009465,0.000005567147,0.00001387,0.000008864787,0.001423591],"genre_scores_gemma":[0.002130497,0.9954755,0.0002174816,0.0006765762,0.0003719333,0.00001176891,0.00002290696,0.000002230723,0.001091117],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004589795,"threshold_uncertainty_score":0.01535439,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059936546","doi":"10.1053/j.seminoncol.2013.09.009","title":"Renal and Pulmonary Late Effects of Cancer Therapy","year":2013,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Intensive care medicine; Cancer; Chemotherapy; Disease; Radiation therapy; Hematopoietic stem cell transplantation; Epidemiology; Pulmonary toxicity; Kidney disease; Natural history; Pathogenesis; Transplantation; Oncology; Toxicity; Internal medicine; Immunology","authors":[{"name":"Roderick Skinner","is_ca":false},{"name":"Rana Kaplan","is_ca":false},{"name":"Paul C. Nathan","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0108382550257794,"gpt":0.3274288663241047,"spread":0.3165906112983253,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001204033,0.0002656428,0.0007057825,0.0006444781,0.0003518045,0.0009871207,0.0004548548,0.0005256116,0.005738702],"category_scores_gemma":[0.00208294,0.0001652513,0.0008476809,0.0003922513,0.0003795173,0.0004401684,0.000319943,0.001206253,0.0006134637],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001039849,"about_ca_system_score_gemma":0.001000738,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001610621,"about_ca_topic_score_gemma":0.002566541,"domain_scores_codex":[0.9993993,0.0002775507,0.00003079645,0.00004324158,0.0001138983,0.0001352084],"domain_scores_gemma":[0.9979402,0.000837296,0.0004259277,0.0001763658,0.0002529036,0.000367265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03345836,0.00269935,0.3363509,0.001511154,0.001471007,0.03276355,0.0004765989,0.00244253,0.09832709,0.01224107,0.006417871,0.4718407],"study_design_scores_gemma":[0.0009694321,0.009605129,0.783958,0.0003674966,0.001513606,0.06626388,0.0003736907,0.002496135,0.07248206,0.004312725,0.05759992,0.00005793081],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.8035878,0.1145752,0.007441113,0.003534264,0.000351592,0.000165068,0.001049849,0.0002926793,0.06900246],"genre_scores_gemma":[0.9819967,0.00584482,0.0006433034,0.0005572565,0.0003927091,0.00002178161,0.0003966857,0.00004120113,0.0101055],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.005738702,"threshold_uncertainty_score":0.01919788,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092841476","doi":"10.1053/j.seminoncol.2003.12.015","title":"Antiangiogenic drugs and current strategies for the treatment of lung cancer","year":2004,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Lung cancer; Angiogenesis; Cancer; Vascular endothelial growth factor; Chemotherapy; Oncology; Bevacizumab; Clinical trial; Mesothelioma; Cancer research; Immunology; Internal medicine; Pathology; VEGF receptors","authors":[{"name":"Robert S. Kerbel","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03280033381728383,"gpt":0.4069733212260214,"spread":0.3741729874087376,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001154563,0.001251408,0.001999675,0.002042834,0.0004384199,0.001358426,0.001566534,0.001947057,0.004497534],"category_scores_gemma":[0.000918861,0.0003815372,0.0005665408,0.002378799,0.001023475,0.002132186,0.0005950811,0.003741748,0.003106978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00101632,"about_ca_system_score_gemma":0.001090216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001266025,"about_ca_topic_score_gemma":0.003141008,"domain_scores_codex":[0.9997553,0.00004476737,0.00002683503,0.00003838486,0.0001056512,0.00002911063],"domain_scores_gemma":[0.9994973,0.0002651804,0.00004981656,0.00001587197,0.0001089077,0.000062981],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002213691,0.0001485493,0.0001384258,0.005160814,0.00007408856,0.0003145125,0.00003968418,0.0005992664,0.002158761,0.00580185,0.05292747,0.9324152],"study_design_scores_gemma":[0.00008824629,0.0001596024,0.0005669686,0.001166138,0.0001078611,0.001554409,0.00004098413,0.0001694632,0.0005885873,0.002978692,0.9925604,0.00001869781],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008001806,0.998001,0.0002296598,0.0004365102,0.0004194574,0.000004771996,0.000008713302,0.000009978699,0.0008098202],"genre_scores_gemma":[0.0005494723,0.9971774,0.0003642367,0.0003702144,0.0004581908,0.00001071019,0.0000256302,0.000001941512,0.001042191],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004497534,"threshold_uncertainty_score":0.0150457,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2114829356","doi":"10.1053/j.seminoncol.2009.06.006","title":"Small Round Cell Sarcomas","year":2009,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Sarcoma; Chemotherapy; Radiation therapy; Chromosomal translocation; Lymphoma; Leukemia; Clear-cell sarcoma; Cancer; Oncology; Pathology; Cancer research; Internal medicine; Biology; Genetics","authors":[{"name":"Stephen L. Lessnick","is_ca":false},{"name":"Angelo Paolo Dei Tos","is_ca":false},{"name":"Poul H. Sorensen","is_ca":true},{"name":"Palma Dileo","is_ca":false},{"name":"Laurence H. Baker","is_ca":false},{"name":"Stefano Ferrari","is_ca":false},{"name":"Kirsten Sundby Hall","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08633677207263338,"gpt":0.386383685293941,"spread":0.3000469132213076,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002784281,0.0008176749,0.00111531,0.002646834,0.0001987688,0.0006219207,0.0005428176,0.0005266618,0.003825875],"category_scores_gemma":[0.0006298192,0.0002680462,0.0003279533,0.002306122,0.0004750684,0.001279758,0.0006206213,0.0008250995,0.001730557],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005158232,"about_ca_system_score_gemma":0.0008183464,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007838072,"about_ca_topic_score_gemma":0.002936504,"domain_scores_codex":[0.9998837,0.00001555743,0.00002278901,0.00002315186,0.00004045863,0.00001440381],"domain_scores_gemma":[0.9997742,0.00009751094,0.0000546419,0.00001103741,0.00003989597,0.00002278774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004567349,0.00002368484,0.0002008904,0.008093211,0.000051774,0.000677452,0.00002967233,0.0003182783,0.001831062,0.0009073129,0.02792334,0.9598978],"study_design_scores_gemma":[0.00002837163,0.00008648714,0.001143741,0.002758867,0.0002208876,0.009612235,0.00006053163,0.0001163853,0.001068467,0.001037164,0.9838458,0.00002113849],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003200062,0.9970611,0.0002501908,0.000252953,0.0003201082,0.000007574594,0.00002243279,0.00001505139,0.001750539],"genre_scores_gemma":[0.002759593,0.9947397,0.0002836415,0.0003054878,0.0003034952,0.000008042071,0.00005500068,0.000002575951,0.001542429],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003825875,"threshold_uncertainty_score":0.01279885,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2074340276","doi":"10.1053/sonc.2003.50042","title":"Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimenia","year":2003,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Hyaluronan synthase; Extracellular matrix; Hyaluronic acid; Immune system; Multiple myeloma; Waldenstrom macroglobulinemia; Extracellular; Cancer research; Molecular biology; Cell biology; Medicine; Biology; Pathology; Immunology; Lymphoma; Genetics","authors":[{"name":"Sophia Adamia","is_ca":true},{"name":"Mary Crainie","is_ca":true},{"name":"Jitra Kriangkum","is_ca":true},{"name":"Michael J. Mant","is_ca":true},{"name":"Andrew R. Belch","is_ca":true},{"name":"Linda M. Pilarski","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005451976096725701,"gpt":0.2586122874170537,"spread":0.253160311320328,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002045432,0.0004254313,0.0003574181,0.002333615,0.0004545971,0.0004804708,0.0002617879,0.0005292615,0.001256196],"category_scores_gemma":[0.002000765,0.0002324407,0.0002177494,0.001121495,0.0003795209,0.0002923743,0.000227859,0.0002975891,0.0001729435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002052995,"about_ca_system_score_gemma":0.0002036443,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001149508,"about_ca_topic_score_gemma":0.0006220348,"domain_scores_codex":[0.9997906,0.00003957664,0.00003206799,0.00003545114,0.00004870954,0.00005359531],"domain_scores_gemma":[0.9993716,0.0002540658,0.0001706329,0.00002632319,0.00005505805,0.0001224582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007040683,0.00004447072,0.9406664,0.00004013497,0.00005175265,0.02966664,0.0004783865,0.0001358098,0.0232372,0.0001460077,0.0001899509,0.004639262],"study_design_scores_gemma":[0.00002188524,0.0001510523,0.9486955,0.00001007656,0.0001086742,0.04528725,0.0004029823,0.000634932,0.004002322,0.000226382,0.0004458775,0.00001296483],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989795,0.0002909122,0.0001049381,0.00004945353,0.00000824672,0.000003704882,0.00007335272,0.000009327727,0.0004805105],"genre_scores_gemma":[0.9997668,0.00006471485,0.00004804344,0.00001151601,0.00001155978,0.000002629895,0.00003894036,0.00000146591,0.00005432713],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002333615,"threshold_uncertainty_score":0.004202425,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2792041391","doi":"10.1053/j.seminoncol.2018.01.009","title":"Cell-free DNA as a post-treatment surveillance strategy: current status","year":2017,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"Medicine; Minimal residual disease; Epigenetics; Cell-free fetal DNA; Computational biology; Circulating tumor DNA; Cancer; DNA; Bioinformatics; Internal medicine; Genetics; Biology; Gene","authors":[{"name":"Justin Burgener","is_ca":true},{"name":"Ariana Rostami","is_ca":true},{"name":"Daniel D. De Carvalho","is_ca":true},{"name":"Scott V. Bratman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04472230872259286,"gpt":0.3930149068200702,"spread":0.3482925980974774,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001167739,0.0007392798,0.001444703,0.001022167,0.000218924,0.00156169,0.001107944,0.001396095,0.003661398],"category_scores_gemma":[0.001337635,0.0002272411,0.0005132621,0.0008792446,0.0009332835,0.001640399,0.0008627899,0.00199469,0.001898854],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006797658,"about_ca_system_score_gemma":0.001189809,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000577328,"about_ca_topic_score_gemma":0.001219484,"domain_scores_codex":[0.9997037,0.00006731744,0.00002914849,0.00007240036,0.00008813918,0.00003920171],"domain_scores_gemma":[0.9991579,0.0005642122,0.00008834058,0.00002434496,0.000108159,0.00005703327],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001616073,0.00008110169,0.0002789873,0.008934043,0.00006986317,0.0001350757,0.00004566728,0.0003694677,0.002111877,0.004235983,0.01626486,0.9673114],"study_design_scores_gemma":[0.00004063459,0.0003074727,0.0007631979,0.003860518,0.0002266375,0.00141466,0.0001160295,0.0002316527,0.002400768,0.003444143,0.9871596,0.00003470067],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001666995,0.9982458,0.0003206304,0.0003844858,0.000235449,0.000004452973,0.00001664689,0.000009106894,0.0006168716],"genre_scores_gemma":[0.002236645,0.9957924,0.0004769641,0.0005502563,0.0002961149,0.00001350095,0.00005210226,0.000003740167,0.0005782503],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003661398,"threshold_uncertainty_score":0.01224858,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2100143077","doi":"10.1053/j.seminoncol.2005.02.013","title":"Redefining Bronchioloalveolar Carcinoma","year":2005,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Histopathology; Adenocarcinoma; Lung cancer; Pathology; Carcinoma; Cancer; Natural history; Lung; Internal medicine","authors":[{"name":"Janessa Laskin","is_ca":true},{"name":"Alan B. Sandler","is_ca":false},{"name":"David H. Johnson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04757776916274788,"gpt":0.4422308290928328,"spread":0.394653059930085,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000661794,0.0007305514,0.001576428,0.001692865,0.0002447496,0.0006897197,0.0008561437,0.001155223,0.003154492],"category_scores_gemma":[0.0008560047,0.0003068451,0.0004535364,0.001321432,0.0005349775,0.001269271,0.0005592185,0.001593851,0.001601364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006320206,"about_ca_system_score_gemma":0.0007700756,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008598922,"about_ca_topic_score_gemma":0.003012795,"domain_scores_codex":[0.9998264,0.00003668668,0.00003009728,0.00003106949,0.00005424754,0.00002149885],"domain_scores_gemma":[0.9997305,0.0001374631,0.00004861287,0.0000121867,0.00005253158,0.00001865505],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008540155,0.00004473427,0.0001387106,0.009745653,0.00009252613,0.0004059304,0.00003819718,0.0003125418,0.002131164,0.001575584,0.03051567,0.9549139],"study_design_scores_gemma":[0.00007050271,0.0001360869,0.0009056699,0.002821039,0.0002269488,0.002694993,0.00003998914,0.00009815599,0.001371489,0.0009030128,0.9907174,0.0000147513],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000169348,0.9980856,0.0001393568,0.0003756418,0.0003996799,0.000004581793,0.000009335934,0.000007336138,0.0008089906],"genre_scores_gemma":[0.001775497,0.9952955,0.0002861885,0.0008125118,0.0004451164,0.000008961298,0.00002660516,0.000002540938,0.001347096],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003154492,"threshold_uncertainty_score":0.01055282,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2908061515","doi":"10.1053/j.seminoncol.2018.12.006","title":"Medical oncology job satisfaction: Results of a global survey","year":2019,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Healthcare professionals’ stress and burnout","field":"Health Professions","cited_by":26,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Job satisfaction; Oncology; MEDLINE; Patient satisfaction; Internal medicine; Family medicine; Nursing","authors":[{"name":"Michael J. Raphael","is_ca":true},{"name":"Adam Fundytus","is_ca":true},{"name":"Wilma M. Hopman","is_ca":true},{"name":"Verna Vanderpuye","is_ca":false},{"name":"Boštjan Šeruga","is_ca":false},{"name":"Gilberto Lopes","is_ca":false},{"name":"Nazik Hammad","is_ca":true},{"name":"Manju Sengar","is_ca":false},{"name":"Michael Brundage","is_ca":true},{"name":"Richard Sullivan","is_ca":false},{"name":"Christopher M. Booth","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06148639914696993,"gpt":0.4884743871861017,"spread":0.4269879880391318,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003342889,0.0003385074,0.0004254293,0.001343064,0.0006153426,0.0007129972,0.0002753754,0.0007313531,0.00159521],"category_scores_gemma":[0.005247875,0.0002290164,0.0007350021,0.001783682,0.0004953477,0.0007680916,0.001409348,0.000748755,0.0005113951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004368332,"about_ca_system_score_gemma":0.0005661991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003224051,"about_ca_topic_score_gemma":0.003857512,"domain_scores_codex":[0.9982169,0.0006972256,0.0002256346,0.0001301849,0.0003145314,0.0004154947],"domain_scores_gemma":[0.9942349,0.00117739,0.001583278,0.0002152774,0.001352224,0.001436889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001138685,0.0002024219,0.9940962,0.00002818978,0.00003845945,0.00003428306,0.001211895,0.00005798256,0.0001631635,0.00001411922,0.0005270286,0.003512547],"study_design_scores_gemma":[0.00000581363,0.0001678996,0.9975522,0.000005732019,0.000009248589,0.00003759514,0.001706857,0.00005086467,0.0000422194,0.000005970473,0.0004118874,0.000003694885],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969853,0.0001283437,0.00009559344,0.000236258,0.00001776256,0.00003583028,0.0007094108,0.000005523932,0.001786119],"genre_scores_gemma":[0.9980845,0.0001232887,0.0001148514,0.0002547906,0.00002027261,0.00004409783,0.0008186106,0.000006403216,0.0005332847],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003342889,"threshold_uncertainty_score":0.01767904,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2004731110","doi":"10.1053/sonc.2003.50016","title":"Surgical treatment of small cell lung cancer","year":2003,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Chemoradiotherapy; Radiation therapy; Lung cancer; Chemotherapy; Surgery; Clinical trial; Oncology; Internal medicine","authors":[{"name":"Tomasz Jarosław Szczęsny","is_ca":true},{"name":"Aleksandra Szczęsna","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Robert J. Ginsberg","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07881713051370332,"gpt":0.4802093505055259,"spread":0.4013922199918226,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007461836,0.0007231737,0.001871988,0.002068697,0.0002551789,0.0007423872,0.0007851589,0.0007940453,0.002924701],"category_scores_gemma":[0.001217759,0.0002548494,0.0008690374,0.002348309,0.0005666669,0.0007657661,0.0003876973,0.001005701,0.0007651458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006220473,"about_ca_system_score_gemma":0.001016077,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002157348,"about_ca_topic_score_gemma":0.006452121,"domain_scores_codex":[0.9997401,0.00006754669,0.00005137256,0.00004896014,0.00007327211,0.00001875398],"domain_scores_gemma":[0.9994687,0.0003498927,0.00009045528,0.00001189683,0.00005699614,0.00002205644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001751594,0.00007108237,0.0003696114,0.05273918,0.0003607493,0.0002760911,0.00004412207,0.0002905413,0.0007655452,0.0009865022,0.0177259,0.9261956],"study_design_scores_gemma":[0.0002465842,0.0005818578,0.00605354,0.03223165,0.001952542,0.004339972,0.000302705,0.0001349006,0.0008100409,0.001567644,0.951732,0.00004651359],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006349089,0.999546,0.00001839815,0.00005740018,0.00006246462,0.000001897154,0.000004307962,0.000001161479,0.0002449234],"genre_scores_gemma":[0.0006331637,0.9989561,0.00004897861,0.0001255217,0.00007727376,0.000002418826,0.000009738028,3.934232e-7,0.000146434],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002924701,"threshold_uncertainty_score":0.009784102,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2170700422","doi":"10.1053/j.seminoncol.2009.12.005","title":"Adjuvant Chemotherapy for Resected Stage II and III Colon Cancer: Comparison of Two Widely Used Prognostic Calculators","year":2010,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; FOLFOX; Colorectal cancer; Oxaliplatin; Adjuvant; Numeracy; Oncology; Internal medicine; Stage (stratigraphy); Fluorouracil; Adjuvant therapy; Adjuvant chemotherapy; Surgery; Chemotherapy; Cancer; Breast cancer","authors":[{"name":"Aditya Bardia","is_ca":false},{"name":"Charles L. Loprinzi","is_ca":false},{"name":"Axel Grothey","is_ca":false},{"name":"Garth D. Nelson","is_ca":false},{"name":"Steven Alberts","is_ca":false},{"name":"Smitha Menon","is_ca":false},{"name":"Stephan D. Thomé","is_ca":false},{"name":"Sharlene Gill","is_ca":true},{"name":"Daniel J. Sargent","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03339839090572973,"gpt":0.4159180694435799,"spread":0.3825196785378502,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001840689,0.000531021,0.001933811,0.0007316135,0.000230856,0.000708782,0.0004781384,0.000692705,0.0007887013],"category_scores_gemma":[0.004958197,0.0002287866,0.000672864,0.0009640263,0.0004818938,0.0007091691,0.0004620716,0.001125077,0.0000937924],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005886382,"about_ca_system_score_gemma":0.0007110254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008164413,"about_ca_topic_score_gemma":0.001100312,"domain_scores_codex":[0.9990162,0.0005792772,0.00007581638,0.00009082717,0.0001675801,0.00007032053],"domain_scores_gemma":[0.996716,0.002148969,0.0005553273,0.0001398487,0.0001311146,0.0003087397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.6099125,0.005048271,0.1022406,0.0009859162,0.001590701,0.0001742714,0.0005290182,0.004233369,0.009346057,0.0005998976,0.0005155988,0.2648237],"study_design_scores_gemma":[0.07374161,0.4373142,0.4318072,0.0004418995,0.009566118,0.001042315,0.001222851,0.01688512,0.01552167,0.001191013,0.01106203,0.0002040002],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.9830072,0.0153071,0.0004493927,0.0002368124,0.00008572827,0.00005449782,0.000110921,0.00001973618,0.0007284899],"genre_scores_gemma":[0.9941401,0.004278834,0.0008583194,0.0001069466,0.00008231513,0.00005005824,0.0001701697,0.000009640521,0.0003035886],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.001933811,"threshold_uncertainty_score":0.009734631,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2113901864","doi":"10.1053/j.seminoncol.2005.04.019","title":"Current Management of Anal Canal Cancer","year":2005,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Anal cancer; Capecitabine; Irinotecan; Radiation therapy; Oxaliplatin; Anal canal; Oncology; Mitomycin C; Surgery; Chemoradiotherapy; Fluorouracil; Chemotherapy; Internal medicine; Cancer; Colorectal cancer; Rectum","authors":[{"name":"B. Cummings","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07361723804546028,"gpt":0.4536214864930432,"spread":0.3800042484475829,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009074875,0.0008645007,0.00216187,0.002708545,0.0003007912,0.001241174,0.001200996,0.001111169,0.00319873],"category_scores_gemma":[0.001573517,0.0003169173,0.0005979916,0.002741757,0.0005718133,0.001669911,0.0006884476,0.001362342,0.001269916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008217224,"about_ca_system_score_gemma":0.001360798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001904033,"about_ca_topic_score_gemma":0.00555688,"domain_scores_codex":[0.9996476,0.00007791375,0.00006696291,0.00005467001,0.0001227663,0.00003007285],"domain_scores_gemma":[0.9993541,0.0003270084,0.0001260117,0.00001320021,0.0001279565,0.00005174582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007663613,0.0000392773,0.0005307773,0.01673123,0.0001050365,0.0004470934,0.00004602464,0.0002779124,0.0003541365,0.0007434685,0.02317886,0.9574695],"study_design_scores_gemma":[0.00007132618,0.0002020293,0.004460088,0.02487032,0.0007583366,0.006853275,0.0002946224,0.0002265857,0.0003640406,0.001772456,0.9600818,0.0000450478],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008526451,0.999038,0.00006772488,0.0002709269,0.0001307331,0.000001958905,0.000006755745,0.000004548393,0.0003941552],"genre_scores_gemma":[0.0006456662,0.9984995,0.0001407581,0.0002489232,0.0002080289,0.000002652529,0.00002130161,8.231019e-7,0.0002323572],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00319873,"threshold_uncertainty_score":0.01070088,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968524867","doi":"10.1053/j.seminoncol.2010.06.001","title":"Zoledronic Acid Use in Patients With Bone Metastases From Renal Cell Carcinoma or Bladder Cancer","year":2010,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Zoledronic acid; Renal cell carcinoma; Cancer; Placebo; Internal medicine; Oncology; Bladder cancer; Bone disease; Urology; Kidney cancer; Surgery; Pathology; Osteoporosis","authors":[{"name":"Fred Saad","is_ca":true},{"name":"James A. Eastham","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04216482054983896,"gpt":0.3604882786700274,"spread":0.3183234581201885,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002192827,0.0004277281,0.001684569,0.001193248,0.0001100453,0.0003800339,0.0005038088,0.0004521848,0.00167064],"category_scores_gemma":[0.0006239488,0.0001732507,0.0006898607,0.00165117,0.0001643133,0.0003047132,0.000229897,0.0004335571,0.0003262839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003949617,"about_ca_system_score_gemma":0.000833378,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002777898,"about_ca_topic_score_gemma":0.009402742,"domain_scores_codex":[0.9998798,0.00002058771,0.00003121348,0.00001973357,0.00003838016,0.00001018831],"domain_scores_gemma":[0.9998142,0.00009466003,0.00005674667,0.000002890961,0.00002227799,0.000009218201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005511205,0.00005311259,0.002403024,0.0483494,0.001144035,0.0004582796,0.00004517057,0.0003863736,0.001241753,0.0004019406,0.01521762,0.9297482],"study_design_scores_gemma":[0.001634146,0.001559433,0.0594951,0.03144621,0.01534229,0.01595885,0.0003364179,0.0007459457,0.00226075,0.001400266,0.8696949,0.0001255754],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005079225,0.9989545,0.00003453947,0.00008632426,0.00005407746,0.000003035272,0.00003442182,0.000003236093,0.0003219765],"genre_scores_gemma":[0.00572317,0.9935882,0.00009816192,0.0002007777,0.00008282775,0.000005691297,0.00006280684,7.134922e-7,0.0002376426],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002777898,"threshold_uncertainty_score":0.00558883,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}